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Anthocyanins are natural colorants, with potential chemopreventive activity. 
5-Flurouracil (5-Fu) is a widely used cancer chemotherapeutic drug. However, it has 
serious side effects. Objective: To determine whether anthocyanin-rich-extracts 
(ARE) can increase the effectiveness of 5-Fu. Methods: Colon cancer cells were 
treated with ARE in combination with 5-Fu to assess in vitro whether ARE would 
enhance 5-Fu cytotoxicity. In vivo, rats were given diets with or without ARE for 14 
days. On day 11, rats were injected with either 5-Fu or its vehicle. Total blood cells 
counts and pathological analyses were conducted. Results: ARE enhanced the 
growth inhibition by 5-Fu in colon cancer cell lines, but almost had no effect on 
normal colon cells. 5-Fu had serious side effects on the rats. Dietary ARE partially 
reduced the gastrointestinal damage by 5-Fu. Further studies with advanced tumor 
models are needed to assess effect of ARE on 5-Fu tumor inhibition in vivo.
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Chapter 1. Literature Review:  
1.1. Anthocyanins and their anticancer effects 
 
1.1.1. Abstract: Anthocyanins are natural colorants and have many bioactivities, 
including antioxidant, anti-inflammatory, and antitumor activity, and potentially the 
ability to decrease the risk of heart disease. More and more researchers are interested 
in anthocyanins and have conducted considerable work on them. This paper reviews 
the structures, stability, bioavailability and the possible mechanisms of anticancer 
function of anthocyanins. 
1.1.2. Key Words: Anthocyanins, structure, stability, bioavailability, anticancer, 
mechanism 
1.1.3. Introduction 
Anthocyanins are natural colorants and impart attractive colors to vegetables and 
fruits. In recent years, many epidemiological studies showed that high consumption 
of fruits and vegetables have health-promoting benefits, such as protecting against 
oxidant damage, reducing the risk of cardiovascular diseases, improving eyesight, as 
well as being antiinflammatory, antibacterial, antimutagenic, and anticarcingoenic 
[1-5, 12, 15, 17]. These functions partially belong to anthocyanins in the fruits and 
vegetables. Thus, anthocyanins are very promising functional food materials and 
additives.  
 
There are many fruits and vegetables rich in anthocyanins such as berries, purple 
corns, purple cabbages, red soybeans, and purple potatoes [1-3]. Right now some 
kinds of anthocyanin extracts are commercially available like chokeberry, bilberry, 
2
elderberry and grape anthocyanin extracts. Some of them already are used in the food 
industry as natural colorants. This article reviews the recent development about the 
structures, stability, bioavailability, anticancer function and possible mechanisms of 
anthocyanins or anthocyanidin rich extracts from multiple materials. 
1.1.4. The structures of anthocyanins 
Anthocyanins belong to the flavonoids family. In nature, the anthocyanins are present 
as glycosylated forms [4, 5]. The nonglycosylated form is called anthocyanidin (Fig. 
1). There are more than 400 anthocyanins and 17 known naturally occurring 
anthocyanidins (Table 1). Only six anthocyanidins are common in higher plants, 
which are listed in Figure 1. Among the six anthocyanidins, cyanidin is most 
abundant in nature and represents almost 50% of all anthocyanidins. The rank of the 
distribution of the six anthocyanidins is cyanindin (50%), pelargonidin (12%), 
peonidin (12%), delphinidin (12%), petunidin (7%), and malvidin (7%) [4]. Four 
classes of anthocyanins are common in the nature. They are 3-monosides, 3-biosides, 
3, 5-diglycosides and 3, 7-diglycosides. Cyanidin 3-glycoside is the most widespread 
one [4, 6]. 
 
The structures of anthocyanins are related to their function. Regarding the antioxidative 
activity, the B-ring structure has a marked effect on antioxidant activity with 
ortho-hydroxylation and methoxylation substantially increasing antioxidant activity [7]. 
3
Figure 1 Structures of 6 common anthocyanidins and their anthocyanins [7] 
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Table 1 Naturally occurring anthocyanidins [4]
SubstitutionName Abbreviation
3 5 6 7 3’ 4’ 5’
Color
Apigeninidin Ap H OH H OH H OH H Orange
Aurantinidin Au OH OH OH OH H OH H Orange
Capesninidin Cp OH OMe H OH OMe OH OMe Bluish-red
Cyanindin Cy OH OH H OH OH OH H Orange-red
Delphinidin Dp OH OH H OH OH OH OH Bluish-red
Europinidin Eu OH OMe H OH OMe OH OH Bluish-red
Hirsutidin Hs OH OH H OMe OMe OH OMe Bluish-red
6-Hydroxycyanidin 6OHCy OH OH OH OH OH OH H Red
Luteolinidin Lt H OH H OH OH OH H Orange
Malvidin Mv OH OH H OH OMe OH OMe Bluish-red
5-Methylcyanidin 5-MCy OH OMe H OH OH OH H Orange-red
Pelargonidin Pg OH OH H OH H OH H Orange
Peonidin Pu OH OH H OH OMe OH OH Orange-red
Petunidin Pt OH OH H OH OMe OH OH Bluish-red
Pulchellidin Pl OH OMe H OH OH OH OH Bluish-red
Rosinidin Rs OH OH H OMe OMe OH H Red
Tricetinidin Tr H OH H OH OH OH OH Red
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1.1.5. Stability of anthocyanins 
Stability is important for bioactive functions and colors of anthocyanins, and 
especially important for the colorants used for foods. Anthocyanins are not stable 
pigments. The hydrolysis of glucose from the anthocyanin molecules is responsible 
for the pigment degradation during processing [8]. The stability of anthocyanin 
pigments is dependent on several factors, including structure, concentration of the 
pigment, pH, temperature, light intensity and quality, presence of copigments, 
metallic ions, enzymes, oxygen, ascorbic acid, sugars and their degradation products 
and sulfur dioxide [1, 2, 9]. 
 
The chemical structure of anthocyanins is a main factor affecting the stability of the 
anthocyanins. Increases in glycosidic substitution, acylation and methoxylation 
improve the stability of anthocyanins [1, 6, 8]. Acylation with hydroxylated aromatic 
organic acids increases the stability of anthocyanins, but with some exceptions. 
Acylation of cyanidin 3-glycosides and mavidin 3-glucoside distinctly increased their 
antioxidant activity [6]. Methoxylation also increases the stability of anthocyanins [1]. 
Malvidin glycosides are more stable than most other anthocyanins because of the 
dimethoxylation of the molecule.  
 
The pH has a marked effect on the structures of anthocyanins. Anthocyanins exist in a 
variety of protonated, deprotonated, hydrated, and isomeric forms, and the relative 
proportion of these molecules is strongly dependent on pH [10]. Consequently, their 
colors also undergo dynamic changes with the structure change. In acidic media, four 
anthocyanin structures exist in equilibrium: flavylium cation, quinonoidal base, 
carbinol pseudobase and chalcone. The relative amounts of these structures at 
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equilibrium vary with pH and anthocyanins structure [1]. When pH is 1-3, the color 
of anthocyanins ranges from orange to blue-red, and exists predominantly as a 
flavylium cation [10, 11]. As the pH is raised to 4-5, hydration reactions generate the 
colorless carbinol pseudo-base, which can further undergo ring opening to the light 
yellow chalcones, most rapidly at pH 2.5-5 [10, 11]. At pH between 6 and 7, the 
quinonoidal bases through proton transfer from flavylium cation can be further 
converted to blue-purple quinonoid anions [9-12].  
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Figure 2 Structural changes of anthocyanins in aqueous solutions, based on 
transformations of red malvidin-3-O-β-glucoside flavylium cation into possible 
purple quinone methides (A1, A2, and A3), colorless carbinol pseudobase (B), and 




Formation of copigments with other compounds in the mixture or solution could 
increase the stability of anthocyanins. Molecular complexation of anthocyanins with 
other phenols-pigments is the main color-stabilizing mechanism in plants. 
Copigmentation consists of the stacking of the copigment molecule on the planar 
polarizable nuclei of the anthocyanin-colored forms [9]. Acylated anthocyanins have 
high stability due to the intramolecular copigmentation. Nonacylated anthocyanins 
could increase their stability by forming intermolecular copigment [9]. 
Copigmentation can increase the light and temperature resistance of anthocyanins, 
increasing their stability.  
 
Heat and light treatment have negative effects on the stability of anthocyanins. They 
induce the degradation of anthocyanins, decrease the color intensity, and increase the 
polymerization of monomeric anthocyanins [1]. 
1.1.6. Bioavailability 
Bioavailability is the foundation of biological effects of anthocyanins. The 
bioavailability includes the absorption, distribution, metabolism and excretion of 
anthocyanins. For a long time, people thought anthocyanins only can be absorbed in 
their aglycon forms [3, 5, 13]. Some hypotheses came from the studies of absorption 
of flavonoids, especially quercetin [5, 13, 14], because both of them belong to the 
same flavonoid family and share a similar basic structure. Studies suggested that 
quercetin could be absorbed in their glycosylated form [5]. Two possible mechanisms 
for the transport of quercetin glycosides by enterocytes were transport of quercetin 
glycosides by sodium-dependent glucose transporter (SGLT)1, and extracellular 
hydrolysis by lactase phlorizin hydrolase (LPH), a brush border ß-glucosidase, 
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followed by passive diffusion of the aglycone [5, 15, 16]. Similar hypotheses were 
suggested for cyanidins too [5]. 
 
As discussed above, the stability of anthocyanins is affected by the pH, so the pH 
change throughout the gastrointestinal tract may influence the form of anthocyanins 
and may further influence the absorption of anthocyanins. The absorptive sites of 
anthocyanins seem to be stomach, and small intestine [17-19]. Up to now, most 
studies on the bioavailability of anthocyanins have been done with cyanidins and their 
glycosides. However, the opinions regarding the absorption of anthocyanins are still 
contradictory and need to be further confirmed. 
 
Recent studies have shown that the glycosylated cyanidins and other dietary 
anthocyanins (most from berries) could be absorbed in their intact glycosylated forms 
[3, 14, 17, 20-25]. The intact anthocyanins were detected in the plasma and urine of 
human subjects [3, 13, 14, 20, 22, 26] and rats [3, 14, 24-26]. There was a significant 
positive correlation between the serum anthocyanin content and postprandial 
antioxidant status [22]. After oral ingestion, the anthocyanins could be absorbed 
rapidly and had a relatively short half-life [24, 25]. The elimination of plasma 
anthocyanins appeared to follow first-order kinetics and most anthocyanin compounds 
were excreted in urine within four hours after feeding [3, 20, 23]. The mechanism of 
the absorption of anthocyanins as glycosides is still not clearly understood. One study 
suggested that glucose transport receptors in the mucosal epithelium may be involved 
in the process based on the results from quercetin studies [5, 21]. 
Some other studies showed that anthocyanins were metabolized and absorbed as their 
degraded products [3, 20, 27] and these products are present in urine and other tissues 
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as liver and kidney. In vivo, Wu et al. [20] demonstrated that the cyanidins were 
methylated to peonidin and glucuronide conjugate formation after people consumed 
the berry anthocyanins. Felgines et al. [24] found that anthocyanin 3-glucosides were 
partly hydrolyzed by intestinal β-glucosidase releasing aglycons. The aglycons were 
rapidly transformed to other unknown metabolites. Some of the absorbed 
anthocyanins were likely metabolized to some noncolored forms that can not be 
detected [24]. A more recent study [28] showed that human subjects had the capacity 
to metabolize the cyanidin 3-glycosides. The metabolites were glucuronide 
conjugates, methylated and oxidized derivatives of cyanidin 3 - galactoside and 
cyanidin glucuronide. These metabolites may contribute to the bioactive effects of 
anthocyanins. The proposed metabolic pathway is shown in Figure 3 [28]. 
 
Overall, the bioavailability of anthocyanins is very low, lower than 1% [3, 20, 24, 29]. 
Most anthocyanins are nonbioavailable and enter into the colon. In vitro studies 
showed that in colon, the gut microflora could utilize both glycosides and aglycons of 
anthocyanins and degrade them into small molecules [12, 29, 30]. The glycosidic 
bonds within anthocyanins were hydrolyzed by gut microbes. The unstable aglycon 
degraded spontaneously into phenolic acids and aldehydes at neutral pH [29, 30]. The 
metabolites of phenolic acids or/and other yet unidentified compounds may also 
contribute the antioxidant activity of anthocyanins.  
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Figure 3 Pathways for the formation of anthocyanin metabolites in human urine 
as proposed by [28] 
12
1.1.7. Antitumor effects and mechanisms  
Tumor initiation is a very complicated process, which includes damage to DNA, 
accumulation of gene mutations, up- or down-regulation of key enzymes, shutting off 
of signaling transduction pathways. Although different kinds of cancer have different 
mechanisms and characteristics, one of the main features of cancer cells is 
uncontrolled cell proliferation. Tumor cells typically acquire damages to genes that 
directly regulate the cell cycle. Therefore inhibition of the growth of tumor cells, 
regulation of some pathways of cell growth, control of the activities of some critical 
enzymes, and protection of DNA from damage, are effective ways to prevent and/or 
treat cancers [31]. The basic concept to cure cancer is to control the growth of tumor 
cells. Following are some mechanisms of anticancer action of anthocyanins.  
1.1.7.1. Inhibition of the tumor cells growth  
Anthocyanins can effectively inhibit growth of some cancer cell lines, including 
breast cancer MCF7, lung cancer NCI-H460, colon cancer HT29, HCT115 and 
HCT116 [32-34]. There are several different mechanisms to inhibit the cell growth, 
including inhibition of the kinases of cell cycle, inhibition of the endothelial growth 
factor receptor, or alteration of the cyclins of the cell cycle. These will be discussed 
below. 
 
Kang et al. [32] conducted an experiment with APCMin mice1 treated with tart cherry 
extract (rich in anthocyanins), purified tart cherry anthocyanins, and their respective 
 
1ApcMin mice are a mutant mouse lineage predisposed to multiple intestinal neoplasia (Min) due to a 
mutation in the murine homolog of the adenomatous polyposis coli (APC) gene. APC gene is 
considered a gatekeeper in the carcinogenic process. The primary phenotype of ApcMin mice is the 
development of multiple intestinal adenomas [32]. 
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cyanidins. The results showed that the anthocyanins and cyanidins significantly 
reduced the cecal adenomas, comparing with the mice consuming the control diet, but 
colonic tumor numbers and volume were not significantly influenced by the treatment. 
The cherry anthocyanins and cyanidin also reduced cell growth of human colon 
cancer cell lines HT29 and HCT116 [32]. These results suggested that tart cherry 
anthocyanins and cyanidin could reduce the risk of colon cancer [32]. 
 
Similar reports were published by Kamei and research group [35], who tested the 
antitumor effect of methanol extracts from red and white wines and determined that 
the anthocyanins are the active fraction of this extract. Their findings indicated that 
the anthocyanins inhibited the growth of HCT15 cells derived from human colon 
cancer, and AGS cells derived from human gastric cancer. Cells treated with 
anthocyanins were blocked in the S, G2, and M phases of the cell cycle.  
 
In addition, Malik et al. investigated the effect of semipurified anthocyanin-rich 
extract (ARE) from fruits of Aronia meloncarpa E on normal colon and colon cancer 
cell lines [11, 34]. They found 50 µg monomeric anthocyanin/mL could inhibit up to 
60% growth of human HT-29 colon cancer cells. Culturing cells in the presence of 
the extract resulted in the HT29 cells arresting at G1/G0 and G2/M phases of the cell 
cycle. In contrast, almost no effect on the growth of normal colon cells was observed 
when the concentration of ARE was less than 50 µg/mL. 
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Zhao et al. [11] investigated cancer cell growth inhibition effects of three 
commercially available anthocyanin-rich extracts (ARE) from grape (Vitis vinifera), 
bilberry (Vaccinium myrtillus L.), and chokeberry (Aronia meloncarpa E.) based on 
monomeric anthocyanin concentration ranging from 10 µg to 75 µg. They found that 
all three extracts had inhibitory effects on HT29 colon cancer cells, but chokeberry 
ARE was the most effective one. As low as 10 µg /mL, chokeberry ARE could 
significantly inhibit the proliferation of HT29 cells after 24 hour treatment, but not 
the normal nontransformed colon cell line, NCM460. The chokeberry ARE only 
inhibited the NCM460 growth when monomeric anthocyanin concentration was 
greater than 50 µg/mL after 48 hour exposure. This suggested that chokeberry ARE is 
a potential chemopreventive agent for colon cancer, but has little effect on normal 
colon cells. 
1.1.7.2. Antioxidation 
Oxidative reactions can produce a large amount of reactive oxygen radicals, peroxyl 
and other free radicals. In normal physiological conditions, the body keeps the 
balance between oxidation and oxidant scavenging. However, when the free radicals 
exceed the scavenging ability of the body, they can induce extensive damage to the 
lipid, protein, DNA, membranes, and enzymes of the cells. Damage to DNA may 
produce mutations that cause permanent alterations in the genetic messages and 
increase the risk of the carcinogenesis [36]. The oxidative damage is widely accepted 
as one of major causes of diseases including cancer [37]. Therefore, protection of the 
DNA from oxidative damage can prevent gene mutation, decrease neoplastic 
development, and is considered as an effective method to prevent tumor initiation. 
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The chemical structures of anthocyanins cause them to be very potent antioxidants. 
Anthocyanins are electrophilic and can accept the unpaired electrons so that they have 
active antioxidant function. There are many studies reporting that the anthocyanins 
act as antioxidants in vitro and in vivo [10, 38-42]. To date, there are several 
antioxidant mechanisms reported, including hydrogen donation, metal chelation, and 
protein binding [4, 5]. Anthocyanins can effectively clear the reactive oxygen radicals 
and prevent lipid and liver microsome peroxidation. There are also some reports that 
anthocyanins can prevent the oxidation of low-density lipoproteins (LDL) [43].    
1.1.7.3. Protection DNA from damage  
Studies [4, 5] show that anthocyanins can protect the DNA damage via protecting 
DNA from oxidation. One of possible mechanisms is that the anthocyanin forms the 
copigmentation with DNA, and further protects the DNA from the damage [4].  
 
Duthie et al. [36] and Ramirez-Tortosa et al. [43] found that consumption of 
anthocyanins could significantly improve the low antioxidative capacity of rats due to 
the vitamin E deficiency. The level of 8-Oxo-deoxyguanosine (a biomarker of DNA 
damage), which was increased due to the depletion of vitamin E in rats, was 
decreased in rats fed anthocyanins diet compared with the rats consuming the control 
diet. Duthie et al. [36] also demonstrated that diet containing 100 mg/kg 
cyanidin-3-glycoside for 12 weeks could protect the DNA single strand break induced 
by oxidative damage in vitamin E deficient rats.  
1.1.7.4. Inhibition of epidermal growth factor receptor 
Meiers et al. [44] studied the inhibitory effects of different kinds of anthocyanins and 
anthocyanidins on the epidermal growth factor receptor (EGFR). They tested the 
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activity of the tyrosine kinase activity of EGFR isolated from A431 cells and 
measured the phosphorylation of the transcription factor Elk-1. They also compared 
the effects of the different structures of anthocyanins and anthocyanidins on the 
inhibition of EGFR. The results showed that the aglycon forms were more effective 
than the glycosides in inhibition of the EGFR activity, and the cyanidin and 
delphinidin were the most effective compounds among them. For the inhibition of the 
tyrosine kinase activity, the free hydroxyl groups were necessary, especially in the 3 
position. When the hydroxyl group in position 3 was replaced by sugar or methoxy 
group at the B ring, the anthocyanin would lose the ability to inhibit the enzyme 
activity. EGFR is a crucial signaling event in the regulation of the cell growth. Thus 
the results suggest that it could be one of possible pathways for anthocyanidins to 
inhibit growth of cancer cells. 
1.1.7.5. Induction of apoptosis of tumor cells 
Apoptosis, namely programmed cell death, is a mechanism that the body uses to 
control cell numbers and responds to internal or external damages by induction of the 
death of extra cells and damaged cells [45]. Apoptosis is a complex procedure, 
involving proapoptotic and apoptotic suppression proteins like the Bax and Bcl 
families. Recently, induction of apoptosis is a novel target used in cancer prevention 
and therapy [45]. 
 
Katsube et al. [46] tested the apoptosis-inducing effects of ethanol extracts from 
bilberry, which were rich in anthocyanins, in two cell lines, HL60 human leukemia 
and HCT116 human colon carcinoma cells in vitro. At the 4 mg/mL concentration 
based on the dry material, the extract can induce apoptosis significantly in the HL60 
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cells, but not in HCT116 cells. Katsuzaki et al. [47] studied the apoptotic effect of the 
anthocyanins and cyanidins isolated from the skin of red grapes and skin of black 
bean seed coats in human lymphoid leukemia Molt 4B cells. Apoptosis was evaluated 
by observing the induction of DNA ladder fragments in this study. They found that 
the anthocyanins can induce apoptosis in the Molt 4B cells dose-dependently.  
1.1.7.6. Anti-angiogenesis 
Angiogenesis is defined as the formation of new blood vessels from pre-existing ones 
and is active in physiological conditions such as embryonic development, menstrual 
cycle and wound healing [48]. In the normal state, it is an important process for the 
body. But it is also very important for the growth of tumors. Through the angiogenesis, 
the tumor cells gain the nutrition for growth and metastasis. Therefore, inhibition of the 
new blood vessel formation seems to be an effective way to inhibit the growth of tumor 
cells. Anti-angiogenic approach to prevent and treat the cancer is a new priority [37]. 
 
Favot et al. [48] reported the inhibitory effect of delphinidin on angiogenesis in vivo 
in the chorioallantoic membrane model in developing embryo. Their findings showed 
that delphinidin inhibited angiogenesis in vivo in a dose-dependent manner ranging 
from 10-50 µg/embryo. This effect was associated with inhibition of two major steps 
of angiogenesis: endothelial cell migration and proliferation. Delphinidin induced a 
down-regulation of cyclin A and D1 expression and an upregulation of p27 kip1 
expression, an inhibitor of cyclin-dependent kinase (CDK). The authors proposed that, 
in vivo, delphinidin played an important role as an anti-angiogenic compound by 
altering key protein expression in cell migration and cell proliferation. Bagchi et al. 
[37] evaluated the effects of a formulated berry extract, from the combination of six 
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berry extracts including wild blueberry, bilberry, cranberry, elderberry, raspberry 
seed, and strawberry rich in anthocyanins. They reported 50 µg/mL formulated 
extract effectively inhibited the expression of the vascular endothelial growth factor 
(VEGF) in HaCaT cells induced by H2O2 and TNF (tumor necrosis factor). VEGF is 
critical for the tumor blood vessel formation. . 
1.1.8. Summary 
Anthocyanins are beneficial for the health of people and have several different 
bioactivities. Up to now, there are no adverse side effects reported from consumption 
of anthocyanins, so they have the potential to be used for the functional food material 
or combination with chemotherapeutic drug.   
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 1.2. Effects of diet or diet components on the  
chemotherapy of 5-fluorouracil 
 
----Improvement of Sensitivity or Reduction of Adverse Effects 
 
1.2.1. Introduction 
Chemotherapy uses one or several drugs to kill dividing cancer cells, or to inhibit the 
proliferation of cancer cells. 5-Fluorouracil (5-Fu) is an antimetabolic chemotherapy 
drug, a fluorinated uracil base, used for a variety of solid cancers [49-51], liver 
carcinomas, breast cancer, and especially for colorectal cancer [52-55]. It was first 
synthesized in 1957 based on the observation that tumor cells utilized the uracil much 
faster than normal cells [56]. So it is possible that tumor cells also use 5-Fu faster 
because the similar structure of 5-Fu to uracil. Even though 5-Fu has been widely 
used for cancer chemotherapy for more than 50 years, it is still the first line for 
colorectal cancer. However, the response of cancer cells to 5-Fu is only 10-30% 
depending on the sensitivity of the cancer cells [49, 57, 58]. So, clinically, 5-Fu is 
routinely used in combination with methotrexate (MTX), an thymidylate synthase 
inhibitor, leucovorin (LV) and other antitumor drugs to increase its effectiveness and 
response [52, 57]. 
 
Many studies showed that dietary components, antioxidants, proteins, polysaccharide, 
unsaturated fatty acids, have chemopreventive potential and/or modulate the 
chemotherapy effectiveness of 5-Fu [57, 59-62]. The dietary intake of these nutrients 
either can increase the sensitivity of the cancer cells to drugs, or increase the 
tolerance of the host to the toxicity of chemotherapy drugs and reduce side effects 
induced by chemotherapeutic agents beyond the traditional nutritional value.  
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This review focuses on dietary components, especially antioxidants, which have been 
most studied in combination with 5-Fu chemotherapy for cancer treatment, or side 
effect reduction.  
1.2.2. 5-Fu Introduction 
1.2.2.1 The structure of 5-Fu 
5-Fu is a derivative of uracil. It is fluorinated at position 5 on the ring of uracil. This 
structure is very similar to uracil (Figure 5). Because it is similar to this base, it was 
expected to have the same metabolic pathway of uracil. However, it is incorporated 
into DNA and inhibits the cancer cell DNA synthesis and cell division through 
different pathways. The structures of 5-Fu and base analogues are shown in Figure 4.  
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Figure 4. Structures of 5-Fu and its base analogues [47] 
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1.2.2.2 Metabolic pathways of 5-Fu  
5-Fu is not active. It is a prodrug, which needs to be converted into its active 
metabolites by intracellular reactions through anabolic pathways [56, 63, 64]. The 
metabolic pathways of 5-Fu are cell-line dependent. The three key cytotoxic 
metabolites are 5-fluro-2’-deoxyuridin-5’-monophosphate (5-FdUMP) (inhibits TMP 
synthetase and can convert to FdUTP), FUTP (incorporated into RNA synthesis), and 
FdUTP (incorporated into DNA) [65]. So, the cytotoxicity of 5-Fu is associated with 
the activities of anabolic enzymes [56]. The anabolic pathway of 5-Fu is shown in 
Figure 6. 
 
In addition, 5-Fu also undergoes catabolic metabolism using the same pathway as 
uracil and thymine [56]. The initial reduction of 5-Fu to dihydro 5-Fu is catalyzed by 
dihypyrimidine dehydrogenase (DPD) [64], the key rate-limiting enzyme in 5-Fu 
degradation. More than 80% of administrated 5-Fu was eliminated by metabolism 
through DPD [64]. DPD activity is high in human liver and variable in tumor tissues. 
The higher the DPD enzyme activity, the lower the cytotoxicity of 5-Fu [64]. In order 
to increase the antiproliferative effect of 5-Fu, various modulators were developed to 
inhibit the activity of DPD, to inhibit the degradation of 5-Fu and increase 5-Fu 
content in tissues. 
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Figure 5. Metabolic pathway of 5-Fu [55]  
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1.2.2.3 Mechanisms of 5-Fu effect 
So far, there are three main mechanisms by which 5-Fu is thought to exert its 
cytotoxic effects on cancer cells [52]. These are: inhibition of the activity of 
thymidylate synthase, DNA-directed cytotoxicity, and RNA-directed cytotoxicity. 
Each mechanism will be discussed below. 
 
 Inhibition of the activity of thymidylate synthase (TS). One metabolite of 5-Fu, 
5FdUMP, inhibits the activity of TS, a key enzyme of deoxythymidine 
triphosphate (dTTP) synthesis, by formation the stable complex with TS and 5, 
10 methylenetetrahydrofolate (CH2-THF)[51]. TS is the key enzyme that 
catalyzes the de novo synthesis of thymidylic acid which will be converted to 
dTTP, a substrate of DNA. Through this pathway, 5-Fu finally inhibits the 
synthesis of DNA and depletes the DNA for cancer cells division. This effect is 
expressed as the cell cycle block and/or induction of apoptosis [49].  
 
 DNA-directed cytotoxicity. The metabolite FdUTP of 5-Fu incorporates into 
genomic DNA and results in DNA fragmentation due to the formation of streak 
breaks, gene mutations and base mismatches [55]. After the 5-Fu-induced 
damage of DNA occurs, the tumor suppressor protein p53 can active 
proapoptotic proteins to initiate apoptosis and inhibit cell growth [52].  
 
 RNA-directed cytotoxicity. One of metabolites of 5-Fu, FUTP, incorporates into 
RNA and leads to changes of mRNA expression, inhibition of mRNA splicing, 
and interference with tRNA modification [55, 65].  
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1.2.2.3 The limitation of 5-Fu chemotherapy 
Because 5-Fu is an analogue of uracil, its metabolites can incorporate into RNA and 
DNA, leading to malfunction of these macromolecules [52, 58]. In the end, 5-Fu 
affects all rapid growing cells, normal and abnormal. As a result, the drug not only 
kills tumor cells, but also kills rapidly growing normal cells, including 
gastrointestinal (GI) cells and bone marrow cells [58]. This lack of target 
differentiation limits the use of the drug because the toxicity it creates in the host. 
Toxicity is expressed as vomiting, diarrhea, structural alteration of mucosal cells, 
decreased nutrient absorption, white blood cell (WBC) depression, and decreased 
platelet cells [58]. The most serious toxicities are gastrointestinal toxicity, bone 
marrow inhibition, and immunotoxicity [62] 
 
Gastrointestinal toxicity and bone marrow inhibition are always the dose limiting 
factors and hamper the use of higher and possibly more effective doses of 5-Fu [66]. 
The gastrointestinal damage includes stomatistis, diarrhea, denudation of villi, 
destruction of the integrity of mucosa, an increase of the permeability of intestine, 
and decrease of activities of intestinal enzymes such as thymidine-kinase (the marker 
of the activity of dividing crypt cells), alkaline-phosphatase, sucrase and maltase (the 
markers of digestive function of differentiated enterocytes) [1]. 
 
Intestinal permeability is an index of intestinal barrier function and is used for 
screening and diagnosis of many intestinal diseases [67]. Noninvasive in vivo test 
methods for intestinal permeability were discovered in last decades by measuring 
urinary excretion of orally administrated substances [67]. Disaccharides and 
monosacchrides probes are usually used together for the intestinal permeability test. 
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The urinary excretion ratio of disaccharide/monosacchride is used as an index of 
intestinal permeability because it is relatively stable in normal condition and less 
affected by other factors [67]. In a disease condition, these small, hydrophilic sugars 
penetrate damaged intestinal epithelium far more rapidly than normal, healthy 
mucosa. Thus, the small molecule markers are orally ingested and urine is collected 
to test the content of markers. More damaged intestine results in excretion of more 
probes in urine. Lactulose/L-rhamnose and lactulose/mannitol are the most commonly 
used combination. The ratio of disaccharide/monosacchride above 0.04 is considered 
normal [68]. The use of sucrose as a novel permeability marker for gastroduodenal 
damage was initiated by Meddings [69]. Compared with disaccharide/monosacchride 
markers, the sucrose marker test is simpler, more convenient, and practical for large 
samples screen [69]. Healthy gastrointestinal mucosa is relatively impermeable to 
sucrose. Sucrose is rapidly degraded in the small intestine by sucrase. Increased 
amount of sucrose in urine means the sucrase activity is damaged and the 
permeability of the small intestine is increased [69].  
 
Bone marrow is another target of 5-Fu toxicity because of rapid turnover of bone 
marrow cells. As a result, 5-Fu induces serious myelotoxicity, such as leucopenia, 
anemia, peripheral thrombocytopenia, and medullary erythrocytopenia [62]. In order 
to solve this problem, a variety of myelopoietic growth factors were used in 
combination with 5-Fu clinically to recover or ameliorate myelopeiteic function. 
These factors are granulocyte colony-stimulating factor (G-CSF), macrophage 
colony-stimulating factor (M-CSF), granulocyte macrophage colony-stimulating 
factor (GM-CSF), interleukin (IL) -3, IL-6, IL-11 and stem cell factor [62, 70].  
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1.2.2.4 Current or developing strategies for improving the limitations of 5-Fu 
Because the overall low response and serious adverse side effects, people have been 
looking for approaches to enhance 5-Fu therapeutic index and reduce side effects [55, 
56]. The antitumor and toxic side effects of 5-Fu can be modified by changing the 
dose schedules, route of administration and by using combinations with biochemical 
modifiers such as methotrexate, leucovorin, uridine and dietary compounds [66].  
 
One approach to solve this problem is to increase the toxicity of 5-Fu by combination 
5-Fu with other drugs, that is to increase the tumor cells response rate or sensitivity to 
5-Fu. Leucovorin, (LX), also known as folinic acid, or formyltetrahydrofolate 
(formylTHF), a precursor of 5-10 methylenetetrahydrofolate, is one of the most 
common modulators. By transformation to 5-10 methylTHF, it stabilizes the complex 
of 5-10 methylTHF, 5-Fu, and TS. The complex inhibits the activity of TS and further 
increases the cytotoxity of 5-Fu [56, 71]. Methotrexate (MTX), an antifolate agent, 
one of mechanisms to exert its function by inhibiting activity of TS [52], is another 
anticancer drug routinely used in combination with 5-Fu clinically to increase the 
cytotoxicity of 5-Fu.  
 
The other approach is to reduce side effects of 5-Fu on normal tissues. Selective 
protection of normal host tissues from the toxicity of 5-Fu would allow the use of 
higher, more effective doses of 5-Fu [66]. Dietary modification is one of the effective 
approaches being explored. One of reason that dietary compound can improve the 
effectiveness of 5-Fu is they could increase the host tolerance to 5-Fu. Besides, 
dietary antioxidant compounds could protect the host from oxidative stress resulted 
from cancer and chemotherapy [59, 72].  
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1.2.3. Effects of dietary compounds on 5-Fu chemotherapy 
1.2.3.1 Dietary antioxidants 
Free radical and other reactive oxygen specials (ROS) are necessary for maintaining 
the normal physiological process of organisms in cell signaling, mitochondrial 
respiration, and phagocyte of bacteria [59]. In normal condition, there is a balance 
between ROS and antioxidants system. Cancer and chemotherapy drugs both induce 
excessive free radicals and ROS. Excessive free radicals and ROS will lead oxidative 
stress to organisms, and can involve in cancer initiation and progression [59]. 
Oxidative stress could induce lipid peroxidation and DNA damage. Lipid 
peroxidation prolongs the cell cycle and reduces the chemotherapy effectiveness of 
anticancer drug, because most anticancer drugs affect rapid dividing cells. 
Antioxidants have the potential to scavenge the oxidants produced by cancer and 
chemotherapy drug, and protect lipid from peroxidation, so that they can increase the 
chemotherapy effect and reduce side effects due to oxidative stress [59].  
1.2.3.1.1 Vitamin E   
Vitamin E is a group of naturally lipid-soluble antioxidants including eight 
structurally related tocopherols and tocotrienols [73]. Vitamin E can scavenge ROS 
and protect polyunsaturated lipid from peroxidation [74]. Study findings showed that 
vitamin E also can inhibit cancer cells growth, prevent cancer chronic diseases, and 
enhance cytotoxicity of anticancer drugs [60, 73]. As antioxidants, vitamin E is 




Chancery and associates [57] found that vitamin E antioxidant enhanced the 
antitumor effect of 5-Fu in vitro and in vivo. Vitamin E could increase the sensitivity 
of HCT116 and HCT15 cells to 5-Fu. Both cell lines grew in the presence or absence 
with the approximate IC50 concentration (3 mM) vitamin E together with different 
concentrations of 5-Fu. Addition of vitamin E in the media significantly decreased the 
IC50 of 5-Fu from 3.80 µM to 1.70 µM. They also conducted an in vivo test of the 
combination effect of 5-Fu and vitamin E. Athymic mice bearing HCT116 or HCT15 
tumor were treated with 750 mg/kg vitamin E and / or 5-Fu, or saline negative control 
by introperitoneal (ip) injection. The combination of 5-Fu and vitamin E significantly 
increased the cytotoxic effect of 5-Fu and resulted in the growth cessation in three 
weeks. In addition, apoptotic index tested by TUNNEL method was also significantly 
increased by vitamin E addition in the two 5-Fu treated cell lines. Mechanistic studies 
showed that one of the possible mechanisms that vitamin E increased the sensitivity 
of cancer cells to 5-Fu was to induce a single transcription factor (C/EBPβ),  which 
can further elevate the expression of p21WAF1/CIPI, a cyclin dependent kinase inhibitor 
of cell cycle, and cell death. This process was independent of p53 protein.  
1.2.3.1.2 Vitamin C 
Vitamin C, a water-soluble antioxidant, prevalent in fruits and vegetables, is widely 
used in functional foods, dietary supplements, and cosmetics [75]. Not only can 
vitamin C protect an organism from oxidative stress, but it also can have 
chemopreventive activity by inhibiting tumor promotion [75]. As discussed below, it 
also can improve the chemotherapy effect of anticancer drugs. 
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In order to evaluate the synergistic effect of vitamin C and 5-Fu, Nagy and 
co-workers [76] determined the growth inhibition effect of simultaneous exposure the 
5-Fu and vitamin C in three cell lines, mouse lymphoma, a chemosensitive one, 
HEp-2, a chemoresistant one and a human lung fibroblast cell line. The results 
showed that vitamin C itself did not have antiproliferative effect on fibroblasts, but 
increased the growth inhibition effect of 5-Fu with different concentrations on mouse 
lymphoma with dose-dependent manner once the concentration of vitamin C was 
greater than 5 µg/mL. When the concentration of vitamin C was over 50 µg/mL, 
vitamin C also enhanced the growth inhibitory effect of 5-Fu on HEp-2 
chemoresistant cell line. One of mechanisms by which vitamin C increased the 
antiproliferation of 5-Fu was enhancement of apoptotic cell death. At higher 
concentrations of vitamin C, apoptosis increased.   
 
DeLoecker et al. [77] investigated the synergistic effect of vitamin C and vitamin K3 
combined with chemotherapeutic agents. Fifty percent confluent AN3CA (human 
endometrial adenocarcinama) cells treated with 5-Fu 0.15 µg/mL together with 200 
µM vitamin C and 2 µM of vitamin K3. The growth inhibition increased from 25% 
5-Fu alone to 71% combined with both vitamins. They found that the concentration of 
the 5-Fu and vitamins should be adjusted to proportional to the density of the treated 
cells to exert their best effects.  
1.2.3.2 Folic acid 
Folic acid is a necessary vitamin for people and necessary for healthy neural system 
development. Dietary folic acid deficiency has been observed in cancer patients due 
to the combination of inadequate dietary content, poor dietary intake and absorption, 
31
and increased metabolic needs of tumors [78]. Folic acid is one of substrates of TS. 
So, it is possible that folic acid has the ability to modulate the effect of 5-Fu. 
However, study findings regarding the effects of folic acid on 5-Fu chemotherapy 
were complicated. 
 
Branda et al. [78] found that folate deficiency for six weeks (no folic acid in diet) 
retarded the growth of transplanted MADB106 mammary tumor in Fisher 344 rats 
compared with folate replete diet (2 mg/kg). They also found that folate deficiency 
rats were more sensitive to side effects of chemotherapy. In another experiment, they 
treated rats with three folic acid concentrations diets, folate deficiency, (0 folate), 
replete, (2 mg/kg), and high folate, (2 mg/kg plus 50 mg/kg ip injection) for 7 weeks. 
Then the rats were transplanted with mammary tumor cells and treated with 50 mg/kg 
5-Fu chemotherapy 3 times, once every 4 days. Later, they did another experiment 
with the same treatment as above but with 75 mg/kg 5-Fu. The findings were that 
high folate diet increased the host resistance to 5-Fu toxicity, including higher 
survival rate and less weight loss. These results indicated that diet rich in folic acid 
has the potential to reduce the toxic side effects of 5-Fu and that dietary deficiency of 
folic acid increases the toxicity of 5-Fu.  
1.2.3.3 Glutathione 
Glutathione (GSH), a tripeptide thiol of glutamate, cysteine, and glycine (GluCysGly), 
is a strong antioxidant found in almost all cells [54]. Freshly prepared meat, boiled 
ham, and hamburger are rich in GSH, and fruits and vegetables are moderately high 
[54]. GSH contains a thiol group, which is strongly nucleophilic, and forms a stable 
covalent compound with electrophilic compounds. This character makes glutathione 
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able to form the complex with some antineoplastic agents to lower their activity and 
also lower their toxicity. Some alkylating anticancer drugs are also electrophilic 
agents, which can compete with GSH to form the complex with DNA. So GSH has 
the potential to lower the anticancer effect when in combination with this kind of 
agent [59]. Cozzaglio et al. [79] studied the modulator effect of GSH in combination 
with cisplatin and 5-Fu in metastatic colorectal cancer. First, patients were treated 
with 5-Fu dose of 750 mg/m2 for five days with infusion. After that, reduced GSH 
was administrated via intravenous treatment. One hour later, cisplatin dose of 40 
mg/m2 was administrated in a one-hour infusion for three days. They found that the 
GSH reduced the toxicity of nausea, vomiting and nephrotoxicity induced by cisplatin 
or 5-Fu and cisplatin. This study demonstrated that GSH interfered with the 
cytotoxicity of cisplatin and may have the ability to protect the renal tissues from the 
damage of cisplatin, but GSH had no effect on 5-Fu treatment.  
 
Chen and co-workers [54] found that GSH level in HT29 cells treated with 5 µM
5-Fu increased dramatically compared with nontreated control cells, but when the 
cells were treated with a GSH inhibitor and then 5-Fu, the GSH level decreased 
compared with the control cells. GSH itself did not stimulate the growth of HT29 
cells. They found that 34% increase of GSH level in the cells did not have any effect 
on the cytotoxicity of 5-Fu, but 50% decrease of GSH in the cells had significant 
increasing effect on the cytotocity of 5 and 10 µM 5-Fu.  
1.2.3.4 Docosahexaenoic Acid  
Docosahexaenoic Acid (DHA) is a polyunsaturated fatty acid rich in marine fish. 
Epidemiological studies have shown that diet rich in DHA can lower the risk of heart 
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diseases and cancer [80]. Recent findings suggested that DHA itself can inhibit 
cancer cells growth, decrease side effects of cancer chemotherapy and increase 
sensitivity of cancer cells to anticancer drugs [61, 80, 81]. 
 
Calviello et al. [80] found that DHA can increase cancer growth inhibition effect of 
low dose 5-Fu in four colon cancer cell lines. DHA potentiated the 5-Fu effect by 
downregulating the expression of the apoptotic-suppressing proteins, Bcl-2 and 
Bcl-XL. In their study, two p53 wild type colon cancer cell lines, LS174 and Colo320, 
and two p53 mutant cell lines, HT29 and Colo205, were used. IC20 DHA 
concentrations ranging from 2.5 to 10.1 µΜ were used in four cell lines in 
combination with increasing concentrations of 5-Fu from 0 to 2.5 µΜ. Τhe reason 
they used IC20 DHA was that high concentrations of DHA may cause peroxidation of 
lipid membranes. Results showed that IC20 DHA significantly increased the 
cytotoxic effect of 5-Fu on all four cell lines independent of p53 status. DHA and 
5-Fu had a synergistic effect rather than additive effect. Further study showed that 
combination of 5-Fu and DHA both at their IC20 concentrations could markedly 
induce apoptosis by cell cycle arrest at G2/M phase and by inhibition of expression of 
antiapoptotic protein Bcl-XL and Bcl-2 in LS174 cells.   
 
Intestinal toxicity is one of severe side effects of antitumor therapy. Gomez de Segura 
et al. [61] examined the intestinal protection effect of diets rich in DHA (1%), protein, 
and DHA + protein in 5-Fu-treated male Wistar rats. Rats were given their assigned 
diets for six days (8 rats/group). At day 3, 900 mg/kg 5-Fu was injected by ip in a 
single dose. Results showed that in the rats with DHA rich diet, the intestinal mucosal 
height was not significantly different from control diet group. Diet supplied with 
34
DHA and protein significantly increased mucosa height and recovered it to normal 
level. Diet with DHA and protein also reduced apoptosis of crypt cells in small 
intestine and increased the crypt cells proliferation. These findings suggested that diet 
supplemented with DHA gave moderate protection to the intestine from 5-Fu toxicity, 
and additional supplementation with protein fortified the protection of DHA.  
1.2.3.5 Other compounds 
Liao et al. [62] measured the bone marrow protection effect of a novel high molecular 
polysaccharide isolated from black soybean (PSBS) by liquid chromatography and 
gel filtration in 5-Fu treated mice. Male ICR mice (6 each group) were ip injected 150 
mg/kg 5-Fu single time. Six hours later, 400 mg/kg PSBS was orally administrated in 
drinking water twice a day for five days. The experiment lasted 11 days. PSBS 
treatment could reconstitute the suppressed bone marrow function by increasing 
leukocyte counts, shortening the recovery time of leukocyte counts, increasing 
colony-forming unit-granulocyte/macrophage (CFU-GM) due to toxicity of 5-Fu. So, 
PSBS is a potential mylopoietic agent. 
Horie et al. [72] found that aged garlic extract could protect the small intestine of 
Wistar rats from 5-Fu damage. Rats were treated with 5-Fu 30 mg/kg orally, and 
provided 2% aged garlic extract. The extract reduced the intestinal permeability tested 
with fluorescein iosthiocyanate-labeled dextran (FD-4) by in vitro everted intestine 
technique. This indicated that aged garlic extract may reduce intestinal toxicity of 
5-Fu therapy.  
 
Takano et al. [70] found that (+)-catechin isolated from Actinidea arguta Planch can 
promote bone marrow cells proliferation, recovery of white blood cells counts and 
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platelets counts damaged by 5-Fu. Female C57B1/6 mice were single injected with 
150 mg/kg 5-Fu at day one. (+)-Catechin was ip injected once a day for 9 days after 
5-Fu treatment. The experiment lasted for 16 days totally. The effects of (+)-catechin 
on 5-Fu toxicity were evaluated at day 9 and day 16. One mg/kg and 10 mg/kg 
(+)-catechin significantly increased the numbers of white blood cells and platelets at 
day 9. At day 16, (+)-catechin enhanced the numbers of myelocytes and splenocytes 
remarkedly compared with 5-Fu alone. These findings suggested that (+)-catechin 
may promote the recovery of myleotoxicity induced by 5-Fu.  
 
Protein intake also may alleviate the side effects of 5-Fu treatment. Protein is a 
necessary nutrient for organism growth. In cancer status, absorption of nutrients 
lowers, because of intestinal toxicity of chemotherapy, and possible lead to 
malnutrition of host. Torosian et al. [82] investigated the effect of protein on 5-Fu 
toxicity in a tumor model. Wistar rats with implanted mammary tumor cells were 
treated with 25 mg/kg 5-Fu for 5 days. 5-Fu induced severe leucopenia. Diet 
supplemented with 22% protein significantly increased white blood cell number of 
the rats. In addition, a diet rich in protein reduced diarrhea due to intestinal toxicity of 
5-Fu.  
1.2.4. Summary  
Dietary supplements may modulate chemotherapeutic effect of 5-Fu, either increase 
response rate of cancer cells to 5-Fu, or reduce side effects of 5-Fu and increase host 
tolerance. However, there are no uniform methods and evaluation standards for these 
studies. Mechanisms of their effects are still under determination and most of them 
are still in preclinical study. Thereby, further investigation on effect mechanisms and 
clinical studies are needed. 
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Chapter 2: Enhancement of growth inhibition of 5-flurouracil on colon cancer 
cells by Anthocyanin-Rich Extracts  
2.1. Introduction  
Epidemiological studies have shown that diets rich in fruits and vegetables are related 
to reduced risk of chronic diseases cancers and cardiovascular diseases [83]. There 
are emerging researches that anthocyanins contribute to protective effects of fruits 
and vegetables on chronic diseases. Anthocyanins are water-soluble plant secondary 
metabolites responsible for blue, purple, and red colors of fruits and vegetables [84]. 
In nature, most anthocyanins are glycosylated. The position and number of hydroxyl 
group and types of sugar attachments determine the type and activity of anthocyanins. 
Anthocyanins in berries have the activities of antioxidation, growth inhibition of 
cancer cells, anti-angiogenicity, protection of genomic DNA integrity, and reduction 
of age-related diseases [37]. In vivo and in vitro studies showed anthocyanins are very 
good nutraceutical ingredients. Therefore, fruits and vegetables containing 
anthocyanins are considered to be promising functional compounds for cancer 
prevention and other chronic diseases. Our group’s studies have demonstrated that 
Anthocyanin-Rich-Extract (ARE) from chokeberry had chemopreventive effect on 
HT29 cells [11, 34].  
 
The daily intake of anthocyanins is estimated to be 200 mg in the United States [44, 
85]. Among them, the anthocyanins from berries contribute a very large part, 100-300 
mg in a single portion. Black Chokeberry, native in North America and Russia, 
contains high levels of total phenolics [27]. The berries contain 725–800 mg 
anthocyanins/100 g fresh weight [86]. The anthocyanins in black chokeberry consist 
mainly of cyanidin-3-galactoside and cyanidin-3-arabinoside, which are reported to 
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constitute 64% and 29%, respectively and are found in the peel as well as throughout 
the fruit flesh [87].  
 
5-Flurouracil (5-Fu), an antimetabolic anticancer drug, has been widely used for 
cancer chemotherapy more than 50 years, especially in the advanced stages of colon, 
breast, and prostate cancers [49]. It inhibits the cancer cell growth by inducing 
apoptosis [58], inhibiting the activity of thymidylate synthase (TS) and further 
inhibiting the synthesis of DNA and RNA [58, 65]. 5-Fu is a cytotoxic agent, 
affecting rapid growing cells including cancer cells and some rapid growing normal 
cells including intestinal cells and bone marrow cells. Because of nonselective target 
of 5-Fu, it has certain side effects and those side effects limit its usage and dosage. 
The most serious adverse side effects of 5-Fu are gastrointestinal toxicity, expressed 
as diarrhea, decreased absorption of nutrients, vomiting, bone marrow suppression, 
and immunotoxicity.  
 
The response to 5-Fu of colorectal carcinoma is approximately 20%, relatively low 
[49, 58]. Therefore, people have been trying to find some new regimen or 
modifications of administration schedules to increase the sensitivity of cancer cells to 
5-Fu. Combination with other anticancer drugs or agents is one of these approaches. 
Modulators include cisplatin, N-(phosphoneacetyl)-L-aspartic acid (PALA), 
thymidine, methotrexate, leucovorin (LV) [17]. There were also findings that the 
antioxidants enhanced the cytotoxicity of the chemotherapeutic reagents [57, 58]. The 
antioxidants, vitamin E and vitamin C, sensitized cancer cells to 5-Fu [76]. Based on 
this rationale, we investigated if the chokeberry extract rich in anthocyanin, a strong 
antioxidant, could enhance the sensitivity of colon cancer cells to 5-Fu. Previously, 
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Malik et al. [34] reported that chokeberry extract inhibited growth of colon cancer 
cells to a greater degree than normal cells. Therefore, this experiment also 
investigated the effect of combined 5-Fu and chokeberry extract on normal colon 
cells. The overall goal is to find a combinational treatment that: (1) enhances the 
toxicity of 5-Fu to cancer cells, without increasing toxicity to normal cells to increase 
the effectiveness of the drug, and/or (2) reduces the toxicity of 5-Fu to normal cells to 
reduce side effects.   
2.2 Materials and methods 
2.2.1 Chemicals  
5-Fu powder, purchased from Sigma Chemical Company (St. Louis, MO), was 
dissolved in dimethyl sulfoxide (DMSO) and diluted with cell culture media to 
different concentrations. The final concentration of DMSO was 0.125%. Food grade 
chokeberry (Aronia meloncarpa E.) extract powder (10% Anthocyanin) was supplied 
by Artemis International, Inc. (Fort Wayne, IN). 
2.2.2 Cell culture 
Human colon cell lines, HT29 and SW620, were purchased from American Type 
Culture Collection (Rockville, MD). Both the HT29 cell line and SW620 cell line 
were maintained in flasks in McCoy’s 5A medium (Biowhitaker Inc., Walkersville, 
MD) containing 10% fetal bovine serum (FBS) purchased from Hyclone (Logan, UT). 
The HT29 cell line was isolated from a primary tumor. The SW620 was isolated from 
metastatic site of lymph node originated from colon tumor. The tumor stage of this 
cell line is Dukes’ type C. NCM460, a cell line derived from a normal human colon 
(InCell Corp. San Antonio, TX), grew in M3 Base media (InCell Corp. San Antonio, 
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TX) supplemented with 10% FBS. All these three cell lines were cultured at 37° C in 
a 5% CO2 humidified atmosphere and grew exponentially as monolayers during all 
the courses of all experiments. Five thousand cells were seeded to each well of 
96-well plates. After 24 hours incubation, when the cells grew to the log phase, 
combined 5-Fu and ARE solutions and media control were randomly added to the 
wells. After another 48 hours for HT29, NCM460 or 72 hours for SW620 cell lines, 
the cell growth was assessed. Every treatment was assigned to six wells, and the 
whole experiments were replicated at least three times. 
2.2.3 Cell growth inhibition assay 
Cell growth inhibition was assessed using sulforhodamine B (SRB) method based on 
the in vitro toxicology assay kit sulforhodamine B (Sigma) according to the 
manufacturer’s instruction. The key component of this kit is the dye, sulforhodamine 
B (Acid Red 52). The dye binds to cellular protein and is then solubilized in base. At 
the end of the experiment, cells are briefly washed, fixed and stained with the dye. 
The incorporated dye is then liberated from the cells in a tris base solution. An 
increase or decrease in the number of cells (total biomass) results in a concomitant 
change in the amount of dye incorporated by the cells in the culture. This indicates 
the degree of growth inhibition caused by the test material. Growth inhibition was 
calculated by ODcontrol
tODtreatmenODcontrol − ×100%. 
2.2.4 Fifty percent inhibition concentration test 
Fifty percent inhibition concentration (IC50) is a parameter of sensitivity of targets to 
drugs. It is the concentration that the test material can inhibit 50% cell growth. Five 
thousand colon cells were seeded to 96-well plates growing for 24 hours. Then at 
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least five different concentrations of 5-Fu were added to the plates and incubated for 
another 48 hours for HT29, NCM460 and 72 hours for SW620. The cell inhibition 
was measured by SRB method. The experiments were done three times independently. 
Then the dose-effect curve was drawn according to the average of the inhibition 
percentage of three experiments. The log transformation of the 5-Fu concentration 
was the X axis, and the inhibition percentage was the Y axis. An equation and 
correlation coefficient were obtained by Excel software. With the equation, 50% 
inhibition concentration was calculated [58, 88].  
2.2.5 Chokeberry Anthocyanin-Rich Extract (ARE) preparation 
One gram chokeberry extract powder was dissolved in 10 mL 0.01% HCl acidified 
deionized water, and then the supernatant was semi-purified with C18 cartridge (as 
below). The eluted liquid was concentrated with rotary evaporator and redissolved in 
10 mL acidified water. The ARE was stored in -80 °C until use.  
2.2.6 Solid phase (C18) semi-purification of anthocyanins  
After conditioning the five g C18 cartridge (Waters Corp, Milford) with methanol, the 
cartridge was washed with acidified deionized distilled water to remove the methanol. 
Twenty milliliters supernatant was forced through the cartridge, and then the cartridge 
was washed with two columns acidified water to remove sugar and other polar 
compounds in the extract, which were not adsorbed to the cartridge. Anthocyanins 
and other phenolics were eluted with two columns acidified ethanol (0.01% HCl) and 
collected in a 150 mL boiling flask. The ethanol was totally removed in a rotary 
evaporator at 40 °C under vacuum. The concentrated extract was redissolved in 
acidified water. The monomeric anthocyanins content was tested. The extract was 
stored in aliquots at -80 °C for future use and analysis. Usually, the ARE was 
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prepared just the day before use to insure the anthocyanins are intact and did not 
degrade. 
2.2.7 Determination of monomeric anthocyanin concentration  
The monomeric anthocyanin content of extracts was determined using the pH 
differential method [14]. The absorption value was determined at 510 and 700 nm at 
pH 1.0 and pH 4.5. Anthocyanin content was calculated as cyanidin-3-glucoside, 
because cyanidin is the most abundant anthocyanin, using an extinction coefficient (ε)
of 26900L cm-1 mol-1 and molecular weight (MW) of 449.2 g mol-1.
2.2.8 Statistical analysis 
The results were expressed as means±SE. The normality of the data was tested using 
SAS software (version 9.1, SAS Institute Inc, Cary, NC). One-way ANOVA was 
used for all the data analyses with SAS software to determine if there were significant 
differences between different treatment concentrations. Pairwise comparisons 
adjusted with Tukeys were done once the difference was significant. P<0.05 was 
considered as statistical significant difference 
2.2.9 Combinational 5-Fu and anthocyanin extracts  
Colon cells were exposed to the IC50 concentrations of 5-Fu with and without 
chokeberry ARE at different concentrations of monomeric anthocyanins per mL 
growth media. After 48 or 72 hours treatment, cell growth was assessed using SRB 
assay and the cell growth inhibition percentage was calculated. 
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2.3 Results  
2.3.1 IC50 of 5-Fu on HT29 and SW620 cell lines 
The effects of 5-Fu on the growth of HT29 and SW620 cell lines were dose 
dependent (Figure 6 and Figure 7). The 50-percent growth-inhibitory concentration 
(IC50) for any cell line is simply an index of cytotoxicity or cytostasis. It is a 
parameter often used to compare the effectiveness of compounds in vitro. The lower 
the IC50, the more efficient is the compound in inhibiting the growth of the testing 
cells. The IC50 values were calculated with the graphic method, which is an old but 
most common method for IC50 estimation [21].  
 
The IC50s of 5-Fu for SW620 cells were 89.2 µg/mL and 12.9 µg/mL at 48 hour and 
72 hour, respectively. The IC50 of 5-Fu for HT29 cells at 48 hour was 5.5 µg /mL. 
The IC50 of 5-Fu on HT29 at 72 hour was not determined, because 48 hour was long 
enough to inhibit 50% cell growth. From the IC50 values, it is clear that HT29 cells 
were more sensitive to 5-Fu than the SW620 cells. For future combinational studies, 
the IC50 of HT29 cells at 48 hour and of the SW620 cells at 72 hour were used. The 
SW620 cell line was less sensitive to 5-Fu and needed more exposure time than the 
HT29 cell line. The effect of 5-Fu on both cell lines was time dependent. We exposed 
the cancer cells to IC50 5-Fu concentrations of these two cell lines. IC50 is the 
equitoxic concentration for these two cell lines, so that we could compare the effects 
of the ARE among the two cell lines. 
44



















Figure 6 Dose-effect curve of 5-Fu on HT29 cells at 48 hour 
Five different concentrations (0.13, 0.41, 1.30, 4.11, 13.00 µg/mL) of 5-Fu were 
added to HT29 cells. After 48 hours, cell growth inhibition was assayed with SRB 
method. Values are expressed as mean SE. Results were from three independent 
experiments. Log 5-Fu concentration is X axis. Growth inhibition percentage is Y 
axis. The linear equation was obtained through Excel. IC50 was calculated by 
y=50%.  
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y = 19.732x + 28.102
R2 = 0.9236






















Figure 7 Dose-effect curves of 5-Fu on SW620 cells at 48 and 72 h 
 
Seven different concentrations of 5-Fu (1.0, 5.0, 10.0, 50.0, 100.0, 200.0, 500.0 
µg/mL) were added to SW620 cells. After 48 hours and 72 hours treatment, cell 
growth inhibition was assayed with SRB method. Values are expressed as mean SE. 
Results were from three independent experiments. Log 5-Fu concentration is X axis. 
Growth inhibition percentage is Y axis. The linear equation was obtained through 
Excel. IC50 was calculated by y=50%.  
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2.3.2 The combined effect of ARE and 5-Fu on HT29 cell line 
In the HT29 cell line, addition of ARE increased growth inhibition by 5-Fu (Figure 8). 
Using an IC50 concentration of 5.5 µg/mL 5-Fu, low concentrations of ARE had little 
to no effect on HT29 cells, and the cell growth inhibition was very similar to cells 
treated with only 5-Fu. However, growth inhibition was significant (p<0.05) when the 
concentration of ARE was increased to 50 µg/mL. Compared to inhibition with 5-Fu 
alone (64%), 5-Fu plus 50 µg/mL ARE resulted in over 90% inhibition. Because 
addition of 50 µg/mL ARE resulted in more than 90% growth inhibition, we did not 
























Figure 8 Growth inhibition on HT29 colon cancer cells by IC50 5-Fu and 
different concentrations ARE  
Five thousand HT29 cells were seeded into 96-well plates. After incubation for 24 
hours, 100 µL mixture of ARE with different concentrations (1.56 to 50 µg/mL) and 
IC50 5-Fu were added to the plates. After another 48 hours, the cell growth was assay 
with SRB method. The results came from three independent experiments. Data are 
mean ± SE. Values are expressed in percentage and referred to the control cells. The 
inhibition percentage for control cells was 0.  
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2.2.3 Combined effect of ARE and 5-Fu on SW620 cell line  
In SW620 colon cancer cells, addition of ARE increased growth inhibition by 5-Fu at 
high ARE concentration (Figure 9). Compared with IC50 5-Fu alone, the growth 
inhibition percentage was increased by combination of different concentrations of 
AREs with IC50 5-Fu, and the inhibition percentage was dependent on the dose of 
monomeric anthocyanins. IC50 5-Fu inhibited cell growth by almost 42%. Fifty 
µg/mL monomeric anthocyanins ARE increased the inhibition rate up to 68%, which 





























Figure 9 Growth inhibition on SW620 colon cancer cells by IC50 5-Fu and 
different concentrations ARE 
Five thousand SW620 cells were seeded into 96-well plates. After incubation for 24 
hours, 100 µL mixture of ARE with different concentrations (6.25 to 50 µg/mL) and 
IC50 5-Fu were added to the plates. After another 72 hours, the cell growth was assay 
with SRB method. The results came from three independent experiments. Data are 
mean ± SE. Value are expressed in percentage and referred to the control cells. The 
inhibition percentage for control cells was 0.  
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2.2.4 The combined effect of ARE and 5-Fu on NCM460 normal cell line  
In order to test if ARE also increased the damage by 5Fu to the normal cells, we 
tested growth inhibition effect by combination of the IC50 5-Fu and the different 
concentrations ARE on NCM460 normal colon cell line (Figure 8). The ARE almost 
had no effects on the growth inhibition of 5-Fu even with the highest concentration 50 
µg/mL ARE (60% inhibition), compared with 5-Fu alone (53%). There was no 
significant inhibition difference between the 5-Fu alone and 50 µg/mL ARE+5-Fu. 
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Figure 10 Growth inhibition in NCM460 normal colon cells by IC50 5-Fu and 
different concentrations ARE  
Five thousand NCM460 cells were seeded into 96-well plates. After incubation for 24 
hours, 100 µL mixture of ARE with different concentrations and IC50 5-Fu were 
added to the plates. After another 48 hours, the cell growth was assay with SRB 
method. The results came from three independent experiments. Data are mean ± SE. 
Value are expressed in percentage and referred to the control cells. The inhibition 
percentage for control cells was 0.  
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2.4 Discussion  
2.4.1 ARE enhanced growth inhibition effect of 5-Fu on colon cancer cell lines, 
but had little or no effect on normal colon cell line 
Even though 5-Fu is a widely used colon cancer chemotherapeutic agent, the response 
rate of tumor patients is only 15%-20%. One of the methods to increase the response 
rate is to increase the sensitivity of cancer cells to 5-Fu [23]. In clinical therapy, the 
5-Fu is often combined with folonic acid (LV), cisplatin (CDDP), cyclophosphamide, 
methotrexate or other chemotherapeutic drugs [66]. There were reports that the 
CDDP increased the sensitivity of tumor cells to 5-Fu both in vitro and in vivo. The 
response rate of gastric cancer cells to 5-Fu was increased 43% to 45% by CDDP [24], 
and the response rate could be improved by LV approximately 20% [18]. Some other 
reports found that the antioxidants vitamin E, vitamin C and N-acetylcysteine could 
enhance the susceptibility of colon cells to the 5-Fu by induction of apoptosis [58, 89]. 
Nagy and co-workers [76] tested the antiproliferative effect and apoptosis-inducing 
action of 5-Fu in combination with vitamin C in a mouse lymphoma cell line, HEp-2, 
and a human lung fibroblast cell line [76]. They found vitamin C itself had no effect 
on the proliferation of cancer cells, but it could increase the anticancer effect of 5-Fu 
dose dependently once the concentration of vitamin C was greater than 5 µg/mL. 
When the concentration of vitamin C was over 50 µg/mL, vitamin C also enhanced 
the growth inhibitory effect of 5-Fu on HEp-2, a chemoresistant cell line. The results 
suggested that vitamin C could serve as a potential sensitizer of 5-Fu for cancer 
chemotherapy. 
In the current study, ARE in combination with 5-Fu increased the antiproliferative 
effect of 5-Fu on colon cancer cell lines, HT29 and SW620. The results showed that 
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ARE can enhance the chemosensitivity of HT29 and SW620 cells to 5-Fu. For both 
cell lines, ARE increased the growth inhibition by more than 30% when the 
anthocyanins concentration was 50 µg/mL. At low dose anthocyanins, the 
enhancement effect was very little and not significant, but when dose increased to 50 
µg/mL, the enhanced effect was very significant. This finding suggested that ARE 
had the potential to be a sensitizer for 5-Fu in colon cancer therapy. The difference 
between Nagy’s study on vitamin C and this study was that Nagy also used different 
5-Fu concentrations from 100 µg/mL to 300 µg/mL. In the current study the IC50 
5-Fu was used. Vitamin C was more effective than ARE in combination with 5-Fu. 
Vitamin C increased 5-Fu effectiveness at concentration as low as 5 µg/mL. ARE was 
effective at concentration of 50.0 µg/mL. This difference may be because the 
sensitivity of different cell lines used in these two studies.  
 
The interesting thing was that ARE increased the sensitivity of colon cancer cells to 
5-Fu, but had no effect on the sensitivity of normal colon cell NCM460 to 5-Fu. This 
could be a useful aspect for ARE in combination with 5-Fu. 5-Fu is an 
antimetabolism chemotherapeutic drug. It has serious side effects because it not only 
damages the cancer cells, but also damages the normal cells, especially rapid growing 
cells like epithelial cells in intestines. The side effects are gastrointestinal damage, 
light to serious diarrhea, and apoptosis of normal rapid growing cells [58]. However, 
ARE increased the sensitivity of HT29 and SW620 colon cancer cells to 5-Fu, not the 
normal cells. This indicated that ARE could be a source for side effect reduction of 
5-Fu in clinical use by lowering the dose of 5-Fu administration, because it can 
increase the effectiveness of 5-Fu. Kimura et al. [90] reported that chitosan, a dietary 
fiber, can prevent gastrointestinal toxicity and immunotoxicity induced by 5-Fu in 
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mice, and without loss of antitumor activity. This is similar to what was found in this 
in vitro study. So further animal study of combination of 5-Fu and anthocyanin rich 
extract is necessary to investigate effectiveness of ARE on 5-Fu chemotherapy.  
2.4.2 IC50 test of HT29 cell line and SW620 cell line  
IC50 is a parameter of sensitivity of the targets to drugs. The IC50 of HT29 at 48 
hour (5.5 µg/mL) was much lower than SW620 (89.2 µg/mL), so the HT29 is much 
more sensitive to the 5-Fu than SW620. The IC50 difference of these two cell lines 
was as we expected. The HT29 was isolated from primary colon cancer, and SW620 
was isolated from lymph node metastasized from colon. The SW620 cells were from 
more advanced stage of colon cancer than HT29 cells, so the SW620 cells would be 
expected to be more resistant to anticancer drugs than HT29 cells. We tested the IC50 
for the further combined study of 5-Fu with ARE. With IC50 5-Fu and 50µg/mL ARE, 
the growth inhibition percentage was more than 20% higher than with only 5-Fu 
treatment in both cell lines. Therefore, if we use the dose of 5-Fu lower than IC50 
with 50 µg/mL ARE, it is possible to get 50% growth inhibition percentage, because 
ARE increased the growth inhibition effect of 5-Fu. With the low concentration of 
5-Fu, in the consequence, side effects induced by 5-Fu also will be reduced, because 
the side effects are dose dependent too. This is a good aspect of ARE to be used in 
later chemotherapy studies.  
2.4.3 Mechanism of growth inhibition enhancement by anthocyanins 
5-Fu inhibits the cell growth by several mechanisms, including cell cycle arrest, 
apoptosis induction, and COX enzyme inhibition [91, 92]. Anthocyanins can induce 
cancer cell apoptosis [46]. By induction of apoptosis, inhibition of the enzyme 
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activity or induction of cell cycle arrest, ARE in combination with 5-Fu may increase 
the sensitivity of cancer cells to 5-Fu. 
 
Adeyemo and co-workers [58] found that combining 5-Fu with 5mM vitamin E or 
25mM N-acetylcystein augmented pro-apoptotic Bax protein expression 2.5-3 fold 
compared with 5-Fu alone in the colon cancer cell lines Colo201 and Colo205. One 
of possible mechanisms that vitamin E and N-acetylcystein enhanced the 
susceptibility of colon cells to 5-Fu is to increase apoptosis. Bax protein is a member 
of the pro-apoptotic family, promoting apoptosis by triggering the release of 
cytochrome C from mitochondria [58]. As anthocyanins are also strong antioxidants, 
similar to vitamin E, the induction of apoptosis may be one of the possible 
mechanisms for anthocyanins augmenting the sensitivity of colon cancer cells to 
5-Fu.  
 
The anthocyanidins of cyanidin and delphinidin, are potent inhibitors of the epidermal 
growth factor receptor, shutting off the downstream signaling cascades [44]. 
Therefore, an effect of ARE on the pathway also could be one of mechanisms of 
increasing the sensitivity. However, up to now, there is no study regarding this aspect.  
 
5-Fu moderates the cell cycle stages of growing cells. It blocks all the stages of the 
cell cycles depending on the dose and exposure time [49, 91]. It is possible that ARE 
and 5-Fu may have some synergistic effect when both of them block the same stage 
of cell cycle. However, the real mechanisms of the enhancement effect of ARE on the 
cytotoxicity of 5-Fu to cancer cells are remained to be determined.  
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2.4.4 Schedule of addition of ARE 
When 5-Fu is administrated to patients combined with other reagents, the regimen of 
drug administration is also a very important factor and will affect the therapeutic 
effects. Cho et al. [93] investigated the timing effect of combination of 5-Fu and 
cisplatin (CDDP) on the gastric cancer cell lines. They found that the cytotoxicity of a 
combination of 5-Fu and CDDP against human gastric cancer cells is both cell line 
and schedule dependent and is especially affected by the timing of the CDDP 
treatment. The MKN-1, MKN-28, MKN-45, and MKN-74  cell lines were exposed 
to IC50 5-Fu and CDDP for 72 hours and 8 hours, respectively. Three treatment 
schedules were used for application of  CDDP: before, simultaneously with, and 
after the treatment with 5-Fu. The treatment effect was cell line dependent. For 
MKN-28, MKN-45, and MKN-74, the regimen of addition of CDDP after 5-Fu 
treatment was best. Against MKN-1, the addition of CDDP before 5-Fu treatment was 
best. Therefore, in the future study, different treatment schedules of 5-Fu and ARE 
should be done. In this study, only simultaneous treatment of 5-Fu and ARE was used. 
We should try pretreatment of colon cancer cells with ARE for a certain time then 
followed by 5-Fu treatment or the reverse. In addition, the sensitivity to 5-Fu also cell 
line dependent, so different colon cancer cell lines with different gene types or stages 
should be done in future study with ARE and 5-Fu combinations. 
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Chapter 3: Reduction of side effects of 5-flurouracil by 
Anthocyanin-Rich Extracts in rats 
3.1. Introduction  
Even though 5-Flurouracil (5-Fu) is one of most useful antitumor drugs [44], serious 
side effects including gastrointestinal toxicity, myelotoxicity and immunosuppression 
[44, 83] can affect and reduce the response rate and therapeutic index. Serious side 
effects like nausea, vomiting, diarrhea, and stomatitis result in the patients losing their 
appetites, further effects on malnutrition and weakness such that they have to stop the 
therapy. These side effects limit the acceptable dose, therapeutic time and the 
therapeutic efficacy. Therefore, scientists are trying to find some drugs or natural 
agents, which can improve the sensitivity or/and reduce the side effects of 5-Fu when 
combined with 5-Fu chemotherapy. In this way, physicians can either lengthen the 
therapy treatment time or increase the therapeutic doses, when needed, to achieve 
improved response rates. 
 
Dietary modulation is one of these approaches that have been explored and positive 
impacts on the side effects of chemotherapy have been reported [66]. By reducing the 
toxicity of chemotherapeutic drugs, the normal tissues could tolerate higher doses of 
drugs and enhance their anticancer action. There were reports that dietary fiber 
chitosan, soy protein, and docosahexaenoic acid (DHA) increased the anticancer 
action and prevent the side effects of 5-Fu [50, 61, 83]. Horie et al. also found that the 
aged garlic extract protected the small intestine of rats from antitumor drugs 
methotrexate (MTX) and 5-Fu induced damage [44]. Chokeberry extract powder, rich 
in 10% anthocyanins, has strong antioxidant activity and other bioactivities. In the 
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last study, we demonstrated that the chokeberry ARE had the potential to increase the 
sensitivity of colon cancer cells to 5-Fu in vitro. Matsumoto et al. [27] demonstrated 
that the red pigment in black chokeberry had the potential to protect the gastric 
mucosa of rats from alcohol damage. Valcheva-Kuzmanova and co-workers [94] 
found that pretreatment the rats with the black chokeberry fruit juice decreased the 
gastric mucosal damage induced by indomethacin. Therefore, the aim of this study 
was to determine whether pretreatment with dietary chokeberry ARE could protect 
rats from the acute adverse side effects of 5-Fu. 
3.2 Material and methods 
3.2.1 Chemicals  
5-Fu, powder, purchased from Sigma Chemical Company (St. Louis, MO), was 
diluted in 1.5% polyethylene-glycol (PEG) solution into 25mg/mL and adjusted pH to 
10.0 with sodium hydroxide. Sucrose purchased from Fisher Scientific Company 
(Fair Lawn, NJ) was dissolved in distilled deionized water to 1.0g/mL. Food grade 
ARE of chokeberry (Aronia meloncarpa E.) was supplied by Artemis International, 
Inc. (Fort Wayne, IN). AIN93 diet was purchased from Dyets Inc., PA.  
3.2.2 5-Fu solution preparation 
The solubility of 5-Fu in water is low. It is soluble in 1 N NH4OH (50 mg/mL), 
which yields a clear, colorless to light yellow solution. It is also soluble in DMSO (10 
- 50 mg/mL). Polyethylene-glycol (PEG) has good water solubility and can increase 
solubility of 5-Fu in water. In preliminary study, we found that 1.5% PEG was high 
enough to improve the solubility of 5-Fu to 25 mg/mL.  
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3.2.3 Animal treatment and housing 
Twenty male Sprague Dawley (175-200 g) 6 – 8 weeks age rats were obtained from 
Harlan (Rockville, MD). In the first three days of acclimatization rats were slowly 
weaned from pellet rat chow diet to powdered AIN-93 diet. Rats were randomly 
allocated to four groups of 5 animals each. The groups were (1) control diet + vehicle 
group: AIN93 diet ip injected with vehicle solution, (2) control diet + 5-Fu group: 
AIN93 diet injected with 200 mg/kg body weight 5-Fu, (3) ARE diet + vehicle group: 
AIN93 diet containing 5 g monomeric anthocyanin/kg injected with vehicle solution, 
or (4) ARE diet + 5-Fu group: AIN93 diet containing 5 g monmeric anthocyanin/kg 
injected with 200 mg/kg 5-Fu. The 5-Fu dose was determined by preliminary study. 
In the preliminary study, 400 mg/kg 5-Fu was ip injected to rats. The rats were very 
sick and had very serious diarrhea after 5-Fu treatment. Therefore, 200 mg/kg dose 
was used in this study.  
 
The animals were housed two or three in plastic cages, with wire tops. Powdered diet 
was provided in standard feeding cups. Diet and tap water was available ad libtum.
Artificial light was supplied from fluorescent tubes in a 12 hour light-dark cycle. 
Relative humidity was maintained at 25% - 60%. Health signs were monitored daily 
and clinical signs for all the animals were recorded weekly. Rats were fed their 
assigned diets totally 14 days. On day 11, Group 2 and 4 were ip injected with 5-Fu; 
group 1 and 3 were ip injected with 1.5% PEG, then all the rats were gavaged with 
1.0 mL of a 1.0 g/mL sucrose solution one hour after injection. Urine was collected 
for 6 hours in the metabolic cages right after the gavage and sucrose content in the 
urine was assayed as a measure of intestinal permeability. All rats were euthanized 
with CO2 three days after the injection. Tissues including heart, kidney, spleen, 
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stomach, the entire intestine, and one femur for bone marrow extract were removed 
for pathological analysis. Blood was taken from the tail right before euthanizing the 
rats for hematocrit tests. All animal experiments were conducted in accordance with 
U.S. Animal Welfare Act and U.S. Public Health Service Policy. The University of 
Maryland Institutional Animal Care and Use Committee (IACUC) approved 
experimental protocols. 
3.2.4 Anthocyanin containing diet preparation 
The anthocyanin concentration in diet was chosen based on the previous 
chempreventive animal study performed in our laboratory (Lala et. al., in press). Fifty 
g chokeberry anthocyanin extract powder (containing 10% monomeric anthocyanin; 
monomeric anthocoyanin content was determined by method described above) was 
mixed completely with 950 g of an AIN93 powdered diet, which had been prepared 
to be missing 50 g of cornstarch by Dyets Inc. (Bethlehem, PA). Control diet was 
prepared by mixing 950 g AIN93 diet with 50 g cornstarch. The diets were stored at 4 
°C until use.  
3.2.5 Body weight 
All animals were weighed at the time point of starting the diet treatment and once a 
week before 5-Fu injection. The rats were also weighed on the day of 5-Fu treatment 
and every day after 5-Fu treatment until the last day of the experiment. 
3.2.6 Urine collection 
Right after sucrose gavage, samples of urine were collected for 6 hours from each 
animal in metabolic cages (Mini Mitter Inc., Oregon). The total volume of the urine 
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of each animal was measured. All samples were stored at -80°C for sucrose content 
test. 
3.2.7 Intestinal permeability test 
Intestinal permeability was tested by urine sucrose content as described previously [8, 
52]. The test was done with Sucrose Assay Kit from Sigma Chemical Company (St. 
Louis, MO). The urine sucrose content was expressed by the percentage of sucrose 
administered by mouth. 
3.2.8 Histopathological analysis 
Bone marrow, heart, spleen, liver, stomach and entire intestine were removed 
immediately and fixed in 10% neutral-buffer formaldehyde solution more than 24 
hours. The entire intestine was cleaned with ice cold PBS then fixed. The fixed 
tissues were trimmed and imbedded in the paraffin, cut into sections and placed on 
microscope slides. The slides were stained with hematoxylin and eosin (H&E) 
(American histopathology lab) and examined under a light microscope by a 
pathologist (Dr. Sabine Franke-Carroll). The pathologist was blinded to the animal 
treatment groups until after evaluation was completed. 
3.2.9 Hematological analysis  
Right before the rats were euthanized, 20 µL blood per rat was collected into a 
capillary tube from the tails and stored at 4° C until analysis. The complete blood 
cells count (CBC) test was done by BioReliance Comprehensive Animal Health 
Services (Rockville MD) on the same day.  
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3.2.10 Pathological evaluation 
Pathological damage was scored using descriptive scales. Zero represents within 
normal limits; one is minimal lesion; 2 is mild lesion, 3 is moderate lesion; 4 is severe 
lesion. The average score of each group was calculated.  
3.2.11 Statistic analysis 
For all parameters except pathological scores, the results were expressed as 
means±SE. Normality was tested using SAS software (Version 9.1, SAS Institute Inc, 
Cary, NC). Two-way ANOVA was conducted with SAS software to determine if 
there were significant differences between groups fed ARE diet and control diet, and 
groups of vehicle control and 5-Fu treated rats Pairwise comparisons adjusted with 
Tukeys were done once a significant difference was determined. P<0.05 was 
considered statistically significant difference. 
3.3 Results 
3.3.1 Clinical observation of rats with different diets 
There was no difference between four groups before the 5-Fu treatment regarding 
body weight, activity, or food intake. All rats were very healthy and active. However, 
after 5-Fu treatment, the two groups receiving the 5-Fu treatment displayed diarrhea, 
but not the other two groups without 5-Fu treatment. Diarrhea is one of the side 
effects of 5- Fu as a result of chemotherapy-induced gastrointestinal toxicity and 
inflammation [95]. The feces of rats fed the ARE diet became purple instead of the 
normal brown color. There were no other clinical symptoms were observed. 
Therefore, 200 mg/kg 5-Fu ip injection was high enough to induce the side effects in 
the rats. 
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3.3.2 Effect of ARE and 5-Fu on the body weight of rats 
Body weight is one of the indices of health status of human and experimental animals. 
Body weight loss is a clinical syndrome of damage induced by chemotherapy. Figure 
10 shows the body weight changes of the four groups during the experiment. At the 
beginning of the experiment and the day of injection, there was no significant 
difference among the body weights of the four groups, but at the end of the 
experiment, there were significant body weight differences (table 2).  
 
The average body weights of control diet + vehicle group and ARE diet + vehicle 
group increased an average of 91.2±3.62 and 87.0±5.15, respectively, during the 
whole experiment. There was no significant body weight difference between these 
two groups. In control diet + 5-Fu treatment group and ARE + 5-Fu group, the body 
weight of rats increased at the first 11 days at the same rate as the other 2 groups, but 
decreased dramatically after the 5-Fu treatment and this loss continued until the last 
day of the experiment. From the beginning to the end, the body weight changes of all 
groups are shown in Table 2. There was significant body weight difference between 
group without 5-Fu treatment and groups with 5-Fu treatment. The ARE diet + 
vehicle group had more weight gain than control diet + vehicle group after the 
injection. This suggested that the ARE diet may protect the rats from the damage of 
the vehicle injection, so this group gained more weight during these 3 days. There 
was no significant difference between ARE diet + 5-Fu group and control diet + 5-Fu 
group (P=0.1494). This suggests that the ARE diet could not prevent the body weight 























Figure 11 Effects of 5-Fu and ARE on the body weight of rats. 
The body weight of rat was measured on day 1, day 8 and day 11 to day 14. On day 
11, rats were ip injected with either 5-Fu or vehicle. Values are means ±SE.   
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Table 2 Weight change of rats during the experiment 
Difference of body 







ARE + 5-Fu 
Day 14-Day 11  8.7±1.3a -19.0±1.2b 15.4±1.6c -23.0±3.1b 
Day 14-Day 1  91.2±3.6a 58.0±1.5b 87.0±5.2a 50.6±3.2b 
Day 11-Day 1 77.7 ±2.6a 77.1±1.5a 71.2±4.4a 73.5±2.8a 
The data sharing the same letter do not have significant difference 
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3.3.3 Effect of ARE and 5-Fu on the organs  
Single dose 200 mg/kg 5-Fu significantly reduced the weight of spleen and the ratio 
of spleen weight to body weight compared with control normal rats (Table 3). ARE 
diet had no effect on spleen weight. Pretreatment with ARE did not block the spleen 
weight reduction due to the toxicity of 5-Fu in the experiment period. Both ARE diet 
and 5-Fu had no damaging effect on liver and heart weights. There was also no 
visible effect on their morphological appearance (data not shown).  
 
In order to test the degree of adverse side effects of 5-Fu, a pathological analysis of 
the bone marrow, kidney, stomach, duodenum, jejunum and ileum, was conducted. 
The cellularity of bone marrow of all rats without 5-Fu treatment was within normal 
limits. All rats treated with 5-Fu displayed severe to moderate damage to their bone 
marrow (Table 4). 5-Fu treatment also resulted in the dilation, necrosis of the GI tract 
and villi denudation of the small intestine (Table 4 and Figure 11). 5-Fu treatment 
was more damaging to the intestine than the stomach. However, ARE itself seemed to 
have resulted in some minor to moderate lesions in the stomach and small intestine 
(Table 4), but no severe damage. The small intestine (duodenum, jejunum and ileum) 
was more sensitive to the 5-Fu damage than large intestine (cecum and colon). The 
average lesions of 5-Fu to duodenum, jejunum and ileum regarding to crypt necrosis 
were 3.5, 3.7, and 3.5. The average lesions to cecum and colon were 2.3, and 1.7. 
5-Fu also caused damage on kidney. The average lesion of acute toxic nephropathy 
was 3.8. ARE diet itself also had some damage on kidney. The average lesion of 
acute toxic nephropathy was 2.8. The damage was less severe than the 5-Fu.    
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Control + 5-Fu ARE + Vehicle ARE + 5-Fu 
Spleen 0.29±0.01 0.16±0.01** 0.27±0.01 0.16±0.01** 
Liver 4.10±0.09 4.00±0.01 4.30±0.11 4.30±0.11 
Heart 0.42±0.01 0.37±0.01 0.38±0.01 0.39±0.02 
**P<0.0001 compared with control group 
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Table 4 Organ lesion pathology scores  
 













Bone marrow 7/7 0/7 0/7 0/7 0/7 
Kidney  7/7 0/6 0/6 0/6 0/6 
Stomach  6/6 0/6 0/6 0/6 0/6 
Duodenum  7/7 0/7 0/7 0/7 0/7 
Jejunum  7/7 0/7 0/7 0/7 0/7 
Ileum  7/7 0/7 0/7 0/7 0/7 






Colon  7/7 0/7 0/7 0/7 0/7 
Bone marrow 0/6 0/6 0/6 1/6 5/6 
Kidney (Acute toxic 
nephropathy) 
0/6 0/6 2/6 4/6 0/6 
Stomach  3/6 1/6 2/6 0/6 0/6 
Duodenum (Denuded villi)  0/6 0/6 0/6 1/6 5/6 
Duodenum (Crypt necrosis) 0/6 0/6 0/6 3/6 3/6 
Jejunum (Denuded villi) 0/6 0/6 2/6 0/6 4/6 
Jejunum (Crypt necrosis) 0/6 0/6 0/6 2/6 4/6 
Ileum (Denuded villi) 0/6 0/6 2/6 3/6 1/6 
Ileum (Crypt necrosis) 0/6 0/6 0/6 3/6 3/6 






Colon (Crypt necrosis) 0/6 3/6 2/6 1/6 0/6 
Bone marrow 5/5 0/5 0/5 0/5 0/5 
Kidney (Acute toxic 
nephropathy) 
0/5 0/5 1/5 4/5 0/5 
Stomach (Glandular dilation) 1/4 0/4 3/4 0/4 0/4 
Duodenum (Vacuolation 
crypt)  
0/5 0/5 5/5 0/5 0/5 
Jejunum (Vacuolation crypt) 3/5 0/5 2/5 0/5 0/5 
Ileum (Vacillation villi) 3/5 0/5 0/5 2/5 0/5 






Colon (Crypt necrosis) 4/4 0/4 0/4 0/4 0/4 
Bone marrow 0/5 0/5 0/5 0/5 5/5 
Kidney (Acute toxic 
nephropathy) 
0/5 0/5 2/5 3/5 0/5 
Stomach (Glandular dilation) 2/5 1/5 1/5 1/5 0/5 
Duodenum (Denuded villi)  0/5 0/5 2/5 3/5 0/5 
Duodenum (Crypt necrosis) 0/5 0/5 4/5 1/5 0/5 
Jejunum (denuded villi) 0/5 0/5 2/5 2/5 0/5 
Jejunum (Crypt necrosis) 0/5 0/5 1/5 4/5 0/5 
Ileum (Denuded villi) 0/5 1/5 3/5 1/5 0/5 





Cecum (Crypt drop out) 0/5 1/5 1/5 3/5 0/5 
69
 Colon (Crypt drop out) 0/5 0/5 4/5 1/5 0/5 
70
3.3.4 Myelotoxicity of 5-Fu 
In order to test the effect of ARE on bone marrow suppression of 5-Fu, hematological 
analysis was done. As shown in Table 4, rats receiving an ip injection of 200mg/kg 
body weight 5-Fu had blood parameters that indicated that 5-Fu was high enough to 
inhibit the bone marrow function of rats. Rats treated with 5-Fu had significantly 
lower peripheral blood total leukocyte2 counts including neutrophilia, lymphocyte, 
and monocyte counts. The number of platelets, or thrombocytes (functioning to stop 
the loss of blood from wounds) also was decreased compared with rats without 5-Fu 
treatment. Rats fed the ARE diet had no significant effect on the blood cell counts 
during the experiment comparing with control diet.  
 
2 Leukocytes, or white cells, are responsible for the defense of the organism. In 
the blood, they are much less numerous than red cells. The density of the 
leukocytes in the blood is 5000-7000 /mm3. Leukocytes divide in two categories: 
granulocytes and lymphoid cells or agranulocytes. Granulocytes distinguish 
themselves in neutrophil, eosinophil and basophil. The main function of 
neutrophilia cells is phagcytosis of bacteria. The lymphoid cells, distinguish 
themselves in lymphocytes and monocytes. Lymphocytes defend against the 
attack of pathogenic microorganisms. Monocytes are (precursors of macrophage 
cells and are active in phagocytosis. 
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20.1±1.2  9.2±0.7 9.3±0.6 1.1±0.1 743.1±39.2  
Control + 
5-Fu 
9.1±0.3 * 4.0±0.8* 4.2±0.4* 0.6±0.1* 512.2±81.4*  
ARE + 
Vehicle 
20.4±2.0  8.6±0.9 10.2±0.7 0.9±0.1 700.6±46.4  
ARE + 
5-Fu 
9.2±1.4 * 4.2±0.9* 4.0±0.4* 0.6±0.1* 523.6 ±89.2* 
WBC, white blood count. *P<0.05 compared with control group. K/µL =1000/µL
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3.3.5 Intestinal permeability  
By assaying the ratio (excretion amount/administration amount) of the sucrose marker 
in the urinary excretion, the damage of the intestinal epithelia was tested. The sucrose 
percentages in the urine of rats were 0.09%, 0.82%, 0.21% and 1.03% respectively in 
the control diet + vehicle, control diet + 5-Fu, ARE diet + vehicle, and ARE diet + 
5-Fu groups. The sucrose percentage in the urine of rats treated with 5-Fu was 
significant higher than that of the rats without 5-Fu treatment, either control diet with 
5-Fu or ARE diet with 5-Fu. Sucrose excretion in rats treated with control diet + 5-Fu 























Figure 12 Sucrose content of the urine expressed as a percent of gavaged dose 
One milliliter 1.0 mg/mL sucrose solution was gavaged to rats one hour after 5-Fu or 
vehicle treatment. Urine was collected for 6 hours right after the gavage in metabolic 
cages. Urine volume was determined and sucrose content was measured by sucrose 
testing kit according to the manufacture’s instruction. The data represent the 
mean±SE. * significantly different from control+Vehicle group, P<0.001. 
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3.3.6 Reduction of gastrointestinal damage from 5-fu by ARE  
The small intestine is one of targets damaged by 5-Fu. Rats treated with 5-Fu had 
evidence of damage in small intestine based on the histopathological analysis. The 
damages consisted of villi length reduction due to degeneration and necrosis of villi 
epithelium. Although the character of this change was similar in the control diet + 
5-Fu group and the ARE diet + 5-Fu group, the severity of the lesions in the ileum 
appeared to be overall less in rats of the ARE diet + 5-Fu group (Figure 11). The 
averaged score of denuded villi lesion damage of ileum was 2.0 for ARE diet + 5-Fu 
group, and 2.8 for control diet + 5-Fu group according to the lesion evaluation of 
hispathological analysis (Table 5). Ileal tissues from the ARE diet + vehicle group 
had normal morphology, with average score of 0.0.  
 
Duodenum was very sensitive to 5-Fu toxicity. The average duodenum score was 3.8 
of villi denusion, and 3.5 of crypt necrosis (Table 5) in control diet +5-Fu group. The 
score of normal rats was 0.0. Rats fed ARE diet and treated with 5-Fu had reduced 
duodenal crypt epithelium damage as compared to rats fed the control diet and treated 
with 5-Fu (Figure 12). The average score was 2.6 of villi denusion, and 2.2 of crypt 
necrosis in ARE diet + 5-Fu group (Table 5). Duodenal tissues from ARE diet + 
vehicle only group had normal morphology with the average score of 0.0. The 
average jejunum crypt necrosis lesion score was 3.7 of control diet + 5-Fu group, and 
2.8 of ARE diet + 5-Fu group. 
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a b c
Figure 13 Photomicrographs of ileal sections of demonstrating differences in 
intestinal damage. Representative crosssections of ileum from various treatment 
groups (a) Control diet group with vehicle, 4 x magnification. (b) Control diet with 
5-Fu treatment group, 4 x magnification. (c) ARE diet + 5-Fu treated group, 10 x 
magnification. Sections stained with H&E. According to the lesion evaluation, the 




Figure 14 Photomicrographs of duodenum sections of demonstrating differences 
in intestinal damage. Representative crosssections of duodenum from various 
treatment groups (a) Villi of control diet group without 5-Fu, 10 x magnification. (b) 
Villi of control diet with 5-Fu treatment group, 10 x magnification. (c) Control diet 
with 5-Fu treated crypt epithelium, 60 x magnification. (d) ARE diet + 5-Fu treated 
crypt epithelium, 60 x magnification. (e) Normal control diet group without 5-Fu 
treatment crypt epithelium, 60 x magnification. 
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3.4 Discussion  
Dietary modulation is one of the promised approaches to modulate the toxicity of 
cancer chemotherapy. Dietary folic acid, fiber, lipid, vitamins, fruit juice and some 
other extracts from edible plants such as soybean and garlic have been reported to 
influence the efficacy and toxicity of cancer chemotherapy [27, 44, 61, 62, 89, 90, 94, 
96, 97]. Red pigments in black chokeberry mainly consisting of anthocyanins had a 
significant protective effect on gastric damage induced by ethanol [27]. ARE from 
chokeberry with 10% anthocyanins, may also have the similar bioactivity. 
3.4.1 Effects of ARE on the normal rats 
In this study, 5 g/kg ARE added to the diet had no visible effect on the clinical signs 
of rats during the experimental period. Two groups without 5-Fu treatment were very 
healthy and active. The only visible difference was that the color of the feces of ARE 
diet group was dyed to dark purple by anthocyanins. The tissues of ARE diet + 
vehicle group were overall similar to those of control diet + vehicle group. However, 
some changes were observed more frequently in the ARE diet + vehicle group than 
the control diet + vehicle group. These included dilation of gastric gland, renal 
interstitial edema, bone marrow vacuolation and vacuolation of the small intestinal 
crypt and /or villi epithelium. These changes may be some type of adaptation to the 
high levels of ARE. The significance of these morphological changes is unknown and 
need to be determined. 
3.4.2 The myelotoxicity of 5-fu on rats 
The dose of 200mg/kg body weight 5-Fu was high enough to induce the effects of 
myelosuppression, gastrointestinal toxicity and immunotoxicity in rats. Rats treated 
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with 5-Fu had minor to severe damage to kidney, spleen, bone marrow, and GI tract. 
Bone marrow is the most important organ for production of blood cells. 5-Fu inhibits 
the proliferation of rapid growing cells, including the normal bone marrow cells. As a 
result, it induces serious myelotoxicity, such as leucopenia (white blood reduction), 
peripheral thrombocytopenia (platelet reduction), and medullary erythrocytopenia 
(red blood cell reduction) [62]. In order to solve this problem, a variety of 
myelopoietic growth factors were used with 5-Fu clinically to recover or ameliorate 
myelopeiteic function. These factors include granulocyte colony-stimulating factor 
(G-CSF), macrophage colony-stimulating factor (M-CSF), granulocyte macrophage 
colony-stimulating factor (GM-CSF), interleukin (IL) -3 and IL-6, IL-11 and stem 
cell factor [62, 70]. One study reported that the polysaccharide of black soybean 
promoted (PSBS) myelopoiesis and reconstituted bone marrow after 5-Fu and 
irradiation-induced myelosuppression [62]. Single dose 5-Fu 150 mg/kg was ip 
injected into ICR mice. Six hours later, 400 mg/kg body weight/day of PSBS was 
orally administrated for five days. The results showed that PSBS treatment could 
restore the leukocyte counts reduced by 5-Fu treatment and enhance CFU-GM colony 
formation of bone marrow cells. All these indicated that PSBS had myelopreventive 
activity and may be used to reconstruct the damaged bone marrow system by 5-Fu or 
other chemotherapeutic agents. In present study, the rats were ip injected a single 
dose 200 mg/kg 5-Fu. The total white blood cell count, lymphocyte, neutrophile, and 
monocyte counts were reduced by 5-Fu treatment. The total blood cell count was 
reduced significantly from 20.1±1.20 to 9.1±0.26. The platelet count was significantly 
decreased from 743.1±39.23 to 512.2±81.42. It also severely reduced the precursor 
and mature cell number in bone marrow showed in histopathological study. 5-Fu 
treatment also reduced the weight of spleen and the ratio of spleen weight to body 
79
weight. However, pretreatment the rats with ARE diet did not prevent the inhibition 
of the bone marrow function induced by 5-Fu toxicity. One reason may be that the 
dose of 5-Fu was too high, inducing a high level of toxicity that cannot be prevented. 
In the current study, the Sprague Dawley rats were used and treated with 200 mg/kg 
body weight 5-Fu. In some other studies, different strains of rats (Fischer 344) and 
different doses of 5-Fu were used, with doses as high as 546 mg/kg body weight [97]. 
There may be a tolerance difference between different strains of rats, or there may be 
a difference in formulations as some studies used the injection liquid formulation for 
humans. In this study, 5-Fu powder was dissolved with 1.5 PEG. The PEG vehicle 
may also had some effect on 5-Fu. All these uncertain factors are needed to be further 
determined. 
 
In this study period, ARE diet pretreatment did not prevent some damages of 5-Fu on 
rats. There are several possibilities. One may be that the dose of 5-Fu was too high 
and the toxicity was too strong and can not be recovered in such short time. Another 
possibility may be that the ARE diet percentage was not high or treatment time was 
not long enough to exert its function. The last one may be that some unknown factors. 
So, in future studies, lower 5-Fu doses should be investigated. Also, we killed the 
animals three days after the rats were exposed to 5 Fu, when the peak damage would 
be present. It may be possible that animals on the ARE diet treatment would recover 
faster, and/or show differences in myelotoxicity if the treatment time of anthocyanins 
was extended.  
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3.4.3 Intestine permeability increased by 5-Fu treatment  
Intestinal permeability increase is a common clinical sign of side effects of 
chemotherapy because chemotherapy agents destroy the structure and integrity of the 
intestine. In the normal condition, sucrose is rapidly degraded in small intestine by 
sucrase and is therefore not excreted into urine. Healthy gastrointestinal mucosa is 
relatively impermeable to sucrose. The presence of orally administrated sucrose in the 
urine indicates injury of the small intestine and increased permeability of the small 
intestine [23]. We found that 5-Fu significantly increased the excretion of sucrose in 
urine more than 9 times compared with control diet group. However, pretreatment 
with ARE diets for 11 days did not prevent the sucrose permeability in rats treated 
with 5-Fu. This could be for the same reasons as for myelotoxicity.  
3.4.4 Intestine damage from 5-Fu protected by ARE  
The colonic mucosa is a highly organized dynamic structure with rapid cell turnover. 
Proliferation stem cells at the base of the crypt produce precursor cells that migrate up 
to the crypt and differentiate into functional cells [89]. Chemotherapy-induced 
intestinal injury is a major cause of morbidity and mortality during therapy for cancer. 
As a result, the oncologists have intensified researches into combinational 
chemotherapeutic regimens to improve long term survival and decrease the side 
effects [56]. 5-Fu is well documented to seriously damage the gastrointestinal tract, 
by inhibiting the proliferation of crypt cells and inducing apoptosis of the crypt cells. 
5-Fu also results in the decreased intake of food and decreased intestinal absorptive 
capacity [61]. Furthermore, the patients develop anorexia and malnutrition. Recently, 
interest in diets moderating the toxicity of chemotherapy has increased greatly. 
Kimura et al. [90] reported that chitosan could prevent the myelotoxicity, 
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gastrointestinal toxicity and immunocompetent organic toxicity induced by 5-Fu 
without loss of antitumor activity in mice. The balance between intestinal epithelial 
cell proliferation and cell death maintains intestinal mucosal integrity. The ratio of 
villi height to crypt depth is one of parameter that can be use as a measure of the 
integrity of mucosa [96]. This ratio is altered only when the spontaneous or induced 
apoptosis occurs. When the tissues are under abnormal or damaged due to 
chemotherapy, the ratio will change and the shape of villi also will be affected [96]. 
In this study, the 5-Fu toxic change in the small intestine consisted of reduction of the 
apparent villi length due to degeneration and necrosis of the villi epithelium. The 
denuded duodenum villi and duodenum crypt necrosis scores of organ lesion by 
histopathological analysis of 5-Fu treatment increased to 3.8 and 3.5 from 0.0. By 
comparison, the average score was 2.6 of villi denusion, and 2.2 of crypt necrosis in 
the duodenum of ARE diet + 5-Fu group (Table 5). The average jejunum Crypt 
necrosis lesion score was 3.7 of control + 5-Fu only group, and 2.8 of ARE diet + 
5-Fu group. The organ lesion evaluation (Table 4) and histological analysis (Figure 
11 and Figure 12) results both showed that the ARE diet could prevent the damage of 
intestine by 5-Fu at some extent. It may be either because the damage of the 5-Fu was 
too serious to be totally recovered in such a short time, or because the dose of ARE 
and feeding time were not high and long enough. This result suggested that ARE can 
be a potential intestine protective reagent for chemotherapy drugs, but regarding to 
the mechanism and the appropriate dose of anthocyanins still need to be determined. 
 
One of possible intestinal protection mechanisms of ARE could be prevention of 
apoptosis of intestinal epithelial cells by increasing antioxidant status [96]. Cellular 
lipid peroxidation and production of free radicals are the primary mediators of 
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apoptosis [96]. Anthocyanins are strong antioxidants. They have the potential to 
increase the antioxidative level of the body, scavenge reactive oxygen radicals, 
prevent the formation of lipid peroxides, and suppress membrane peroxidation, so 
they may have the potential to prevent the apoptosis of the intestinal epithelial cells.  
 
Kimura et al. [90] suggested that the co-administration of 5-Fu plus orally 
administrated dietary chitosan 750 mg/kg twice a day to sarcoma 180 transplanting 
ICR mice lowered the 5-Fu level in blood in the first 30 min and also prolonged the 
transiting time of 5-Fu in the intestine. This could be one of reasons that chitoson 
prevented the side effects of 5-Fu such as myelotoxicity and gastrointestinal toxicity. 
Chitosan reduced the 5-Fu incorporation into RNA of small intestine and spleen but 
not into the tumor in the tumor bearing mice. Anthocyanins are charged molecules 
and have the capacity to form complexes with other compounds. Therefore 
anthocyanins may form a complex with 5-Fu, decrease the blood concentration of 
5-Fu. This also could be one possible mechanism to prevent the absorption of 5-Fu in 
the small intestine and lower the toxicity. In this case, we are not sure if they will 
lower the effectiveness of 5-Fu because of the low concentration in blood. This 
should be further determined.  
3.4.5 Antitumor activity of 5-Fu may be affected by ARE 
There were studies that the chitosan could selectively inhibit the uptake of 5-Fu into 
small intestine and spleen tissue by adsorption to the cationic polymer chitosan, but 
without affecting the 5-Fu incorporation into tumor tissue [90]. In the current study, 
the absorption of 5-Fu and the blood levels of 5-Fu were not determined. It is not 
possible to know if the ARE would affect the absorption and metabolism of 5-Fu in 
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the body. It is possible that the ARE had the similar effect forming the complex with 
anthocyanins polymers, reducing the blood level of 5-Fu and releasing the 5-Fu later 
without affecting the antitumor effect of 5-Fu. It also was possible that ARE would 
change the metabolism pathways of 5-Fu, lower the blood level of 5-Fu and lower the 
antitumor effect of 5-Fu. In the present study, tumor model was not used. The 
physiological status of rats may change after the rats bearing tumor and it also would 
influence the uptake, metabolism of 5-Fu and the interaction of 5-Fu and ARE, so 
tumor model should be selected in future study and conduct the same experiment to 
confirm the interaction between 5-Fu and ARE.  
3.4.6 Bioavailability of anthocyanins 
McDougall et al. [85] used in vitro digestion system to investigate the digestion of the 
raspberry anthocyanins. They found that anthocyanins can survive gastric digestion, 
but only 5% can go into serum, and 70% of total anthocyanins can be recovered. 
Some of them are metabolized. The absorption of anthocyanins was influenced by 
other foodstuffs, but the effect was very little. We did not measure the diet intake of 
rats during the experiment. However, we monitored the body weight change and the 
condition of the feces of the animals. Feces of rats with ARE diets were purple 
colored after consuming ARE diets. Feces of rats with AIN93 diets were normal 
brown color. It showed at least some of anthocyanins were not metabolized inside the 
body and excreted by the rats. We know the absorption of the anthocyanins by 
humans and animals are very low. Some reports showed the bacteria in small intestine 
and pH increase lead to the degradation of anthocyanins. Therefore, there still is 
plenty of work to be done for the bioavailability of anthocyanins.  
84
3.5 Summary  
During the whole experiment period, rats were pretreated with 5% ARE diet for 11 
days, and then ip injected 200 mg/kg 5-Fu and vehicle. ARE diet was continued to the 
last day of experiment. Three days after injection, rats were killed. Rats with AIN93 
diet and ARE diet without 5-Fu treatment were active and had no visible damage. The 
rats treated with 200 mg/kg 5-Fu with AIN93 diet and ARE diet had some significant 
difference with rats without 5-Fu treatment. The body weight of rats decreased 
dramatically after 5-Fu treatment. Rats treated with 5-Fu also had lower white blood 
cell counts comparing with the rats without 5-Fu treatment. The intestine permeability 
of rats with 5-Fu treatment increased significantly induced by 5-Fu injection. The 
small intestine was damaged by 5-Fu expressed as villi denusion, crypt necrosis. Even 
though the rats treated with 5-Fu+ARE had similar intestinal damage, the overall 
damage was less severe showed from the histopathological analysis. One of most 
serious adverse effects of 5-Fu chemotherapy is intestinal toxicity. This study showed 
that the ARE diet could partially prevent the small intestine from the 5-Fu damage. It 
could be a potential agent to reduce the side effect of 5-Fu treatment. However, 
further tumor studies and longer treatment period are still needed.   
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Chapter 4: Conclusions 
4.1 The sensitivity of colon cancer cell lines, HT29 and SW620, to 5-Fu was 
significantly increased in the presence of chokeberry ARE, when the monomeric 
anthocyanin concentration was 50 µg/mL. The addition of ARE simultaneously with 
5-Fu increased the growth inhibition of IC50 5-Fu more than 20% for both cell lines 
when the concentration of ARE was 50 µg/mL. However, the same dose ARE had 
little or no effect on the growth inhibition induced by 5-Fu in normal colon cell line 
NCM460. This indicated that ARE may modulate the positive effect of 5-Fu on colon 
tumor cells but not increase the side effect on normal tissues. So ARE could be a 
potential sensitizer of 5-Fu chemotherapy with increasing therapeutic index, but with 
same level side effect.   
 
4.2 Rats treated with 200 mg/kg 5-Fu lost body weight dramatically. The white blood 
cell counts and platelet counts were significantly reduced by 5-Fu myelotoxicity. The 
small intestine permeability was increased significantly by 5-Fu treatment compared 
to rats without 5-Fu treatment. The morphology of small intestine also was changed 
by 5-Fu treatment. The villi height and integrity of mucosa was damaged by 5-Fu 
treatment. Pretreatment of rats with ARE diet for 11 days did not prevent the 
reduction of white blood cell count and platelet counts or body weight lost. So further 
study with longer treatment is needed to fully determine the potential the function of 
ARE. 
 
4.3 Even though the rats treated with ARE diet + 5-Fu had similar small intestinal 
damage as the rats with control diet + 5-Fu, 5 g/kg ARE diet partially protected the 
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small intestine from the damage induced by 5-Fu treatment, including protection of 
the villi denudation and crypt necrosis based on the histopathological analysis. 
Therefore, ARE diet could be a modulator to reduce the intestinal toxicity during the 
5-Fu chemotherapy.   
 
4.4 A tumor-bearing animal model should be used in future studies because of the 
potential differences in the physiological responses during normal and diseased 
conditions. Maybe the response of rats to 5-Fu will change in rats bearing tumors. 
The optimal ARE diet concentration and feeding time also need to be further 
determined.  
 
In conclusion, this represents the first report of evidence of an anthocyanin-rich 
extract enhancing the cytotoxicity of 5-Fu to colon cancer cells in vitro, and reduction 
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